0001065078
false
2022
FY
0001065078
2022-01-01
2022-12-31
0001065078
2022-06-30
0001065078
2023-03-23
0001065078
2022-12-31
0001065078
2021-12-31
0001065078
2021-01-01
2021-12-31
0001065078
us-gaap:CommonStockMember
2020-12-31
0001065078
us-gaap:AdditionalPaidInCapitalMember
2020-12-31
0001065078
us-gaap:RetainedEarningsMember
2020-12-31
0001065078
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-12-31
0001065078
nssi:TotalStockholdersEquityMember
2020-12-31
0001065078
us-gaap:CommonStockMember
2021-12-31
0001065078
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001065078
us-gaap:RetainedEarningsMember
2021-12-31
0001065078
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-12-31
0001065078
nssi:TotalStockholdersEquityMember
2021-12-31
0001065078
us-gaap:CommonStockMember
2021-01-01
2021-12-31
0001065078
us-gaap:AdditionalPaidInCapitalMember
2021-01-01
2021-12-31
0001065078
us-gaap:RetainedEarningsMember
2021-01-01
2021-12-31
0001065078
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-01-01
2021-12-31
0001065078
nssi:TotalStockholdersEquityMember
2021-01-01
2021-12-31
0001065078
us-gaap:CommonStockMember
2022-01-01
2022-12-31
0001065078
us-gaap:AdditionalPaidInCapitalMember
2022-01-01
2022-12-31
0001065078
us-gaap:RetainedEarningsMember
2022-01-01
2022-12-31
0001065078
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-01-01
2022-12-31
0001065078
nssi:TotalStockholdersEquityMember
2022-01-01
2022-12-31
0001065078
us-gaap:CommonStockMember
2022-12-31
0001065078
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001065078
us-gaap:RetainedEarningsMember
2022-12-31
0001065078
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-12-31
0001065078
nssi:TotalStockholdersEquityMember
2022-12-31
0001065078
2020-12-31
0001065078
nssi:ILiADBiotechnologiesLLCMember
2022-12-31
0001065078
nssi:FullyPaidLicensesMember
2022-01-01
2022-12-31
0001065078
nssi:FullyPaidLicensesMember
2021-01-01
2021-12-31
0001065078
nssi:RoyaltyBearingLicensesMember
2022-01-01
2022-12-31
0001065078
nssi:RoyaltyBearingLicensesMember
2021-01-01
2021-12-31
0001065078
srt:MinimumMember
2022-01-01
2022-12-31
0001065078
srt:MaximumMember
2022-01-01
2022-12-31
0001065078
nssi:StockIncentivePlan2022Member
2022-12-31
0001065078
nssi:StockIncentivePlan2013Member
2022-12-31
0001065078
us-gaap:RestrictedStockUnitsRSUMember
2022-01-01
2022-12-31
0001065078
us-gaap:RestrictedStockUnitsRSUMember
2021-01-01
2021-12-31
0001065078
us-gaap:RestrictedStockUnitsRSUMember
2022-12-31
0001065078
us-gaap:RestrictedStockUnitsRSUMember
2021-12-31
0001065078
nssi:ChairmanAndChiefExecutiveOfficerMember
2022-10-01
2022-10-27
0001065078
nssi:ChairmanAndChiefExecutiveOfficerMember
2022-10-27
0001065078
us-gaap:StockOptionMember
2021-12-31
0001065078
us-gaap:StockOptionMember
2020-12-31
0001065078
us-gaap:StockOptionMember
2022-01-01
2022-12-31
0001065078
us-gaap:StockOptionMember
2021-01-01
2021-12-31
0001065078
us-gaap:StockOptionMember
2022-12-31
0001065078
nssi:CostBasisMember
2022-12-31
0001065078
nssi:GrossUnrealizedGainsMember
2022-12-31
0001065078
nssi:GrossUnrealizedLossesMember
2022-12-31
0001065078
nssi:FairValueMember
2022-12-31
0001065078
nssi:CostBasisMember
2021-12-31
0001065078
nssi:GrossUnrealizedGainsMember
2021-12-31
0001065078
nssi:GrossUnrealizedLossesMember
2021-12-31
0001065078
nssi:FairValueMember
2021-12-31
0001065078
nssi:IliadMember
nssi:ClassCUnitsMember
2022-12-31
0001065078
nssi:IliadMember
2022-01-01
2022-12-31
0001065078
nssi:ILiADBiotechnologiesLLCMember
2022-08-24
0001065078
nssi:IliadMember
2021-01-01
2021-12-31
0001065078
nssi:IliadMember
2022-12-31
0001065078
2021-10-01
2022-09-30
0001065078
2020-10-01
2021-09-30
0001065078
2022-03-01
2022-03-25
0001065078
nssi:CoxPatentPortfolioMember
2022-12-31
0001065078
nssi:CoxPatentPortfolioMember
2021-12-31
0001065078
2013-05-01
2021-12-31
0001065078
2022-05-01
0001065078
srt:ChiefExecutiveOfficerMember
nssi:NewEmploymentAgreementMember
2022-03-01
2022-03-22
0001065078
srt:ChiefExecutiveOfficerMember
2022-01-01
2022-12-31
0001065078
srt:ChiefExecutiveOfficerMember
2021-01-01
2021-12-31
0001065078
us-gaap:RestrictedStockUnitsRSUMember
srt:ChiefExecutiveOfficerMember
2022-03-01
2022-03-22
0001065078
us-gaap:RestrictedStockUnitsRSUMember
srt:ChiefExecutiveOfficerMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember
2022-03-01
2022-03-22
0001065078
us-gaap:RestrictedStockUnitsRSUMember
srt:ChiefExecutiveOfficerMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember
2023-03-01
2023-03-22
0001065078
us-gaap:RestrictedStockUnitsRSUMember
srt:ChiefExecutiveOfficerMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember
2024-03-01
2024-03-22
0001065078
us-gaap:RestrictedStockUnitsRSUMember
srt:ChiefExecutiveOfficerMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember
2022-03-01
2022-03-22
0001065078
us-gaap:RestrictedStockUnitsRSUMember
srt:ChiefExecutiveOfficerMember
us-gaap:ShareBasedCompensationAwardTrancheThreeMember
2022-03-01
2022-03-22
0001065078
us-gaap:RestrictedStockUnitsRSUMember
srt:ChiefExecutiveOfficerMember
nssi:ShareBasedCompensationAwardTrancheFourMember
2022-03-01
2022-03-22
0001065078
srt:VicePresidentMember
2022-01-01
2022-12-31
0001065078
srt:VicePresidentMember
2021-01-01
2021-12-31
0001065078
srt:ChiefFinancialOfficerMember
2022-01-01
2022-12-31
0001065078
nssi:GoogleMember
2017-05-08
2017-05-09
0001065078
nssi:FacebookMember
2017-05-08
2017-05-09
0001065078
nssi:NetgearMember
2017-05-08
2017-05-09
0001065078
nssi:AristaNetworksMember
2017-05-08
2017-05-09
0001065078
nssi:RemotePowerPatentMember
2021-01-01
2021-12-31
0001065078
nssi:LicenseesTwoMember
2021-01-01
2021-12-31
0001065078
nssi:BoardOfDirectorsMember
2022-05-29
2022-06-01
0001065078
nssi:BoardOfDirectorsMember
2021-06-11
0001065078
2011-08-01
2022-12-31
0001065078
nssi:BoardOfDirectorsMember
2022-02-01
2022-02-23
0001065078
nssi:BoardOfDirectorsMember
2021-09-01
2021-09-09
0001065078
us-gaap:SubsequentEventMember
nssi:BoardOfDirectorsMember
2023-03-01
2023-03-03
0001065078
us-gaap:SubsequentEventMember
us-gaap:RestrictedStockUnitsRSUMember
2023-03-01
2023-03-03
0001065078
us-gaap:SubsequentEventMember
nssi:SettlementAgreementsMember
2023-01-24
2023-03-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
nssi:Integer
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
☒
ANNUAL REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
For
the fiscal year ended December 31, 2022
☐
TRANSITION REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
For
the transition period from ____________ to ___________.
Commission
File Number: 1-15288
NETWORK-1 TECHNOLOGIES, INC.
(Exact
Name of Registrant as Specified in Its Charter)
Delaware |
|
11-3027591 |
(State
or Other Jurisdiction of
Incorporation or
Organization) |
|
(I.R.S.
Employer
Identification
Number) |
|
|
|
65 Locust Avenue, Third Floor
New Canaan, Connecticut 06840
|
(Address
of Principal Executive Offices) |
Registrant's
telephone number, including area code: (203) 920-1055
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
Trading
symbol |
Name
of each exchange on which registered |
Common Stock $.01 par value |
NTIP |
NYSE American |
|
|
|
Common
Stock, $.01 par value
(Title
of Class)
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No
☒
Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Securities Exchange Act
of 1934. Yes ☐ No ☒
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”,
“smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large
accelerated filer ☐ |
Accelerated filer
☐ |
Non-accelerated filer ☒ |
Smaller Reporting Company ☒ |
Emerging growth
company ☐ |
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. ☐
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in this filing reflect the correction of an error to previously issued financial statements. ☐
Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D.1(b). ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No
☒
The
aggregate market value of the voting and non-voting common stock held by non-affiliates computed by reference to the price at which the
common stock was last sold as of June 30, 2022 was approximately $39,885,677 based on the closing price as reported on NYSE American
Exchange. Shares of voting stock held by each officer and director and by each person, who as of June 30, 2022, the last business
day of the Registrant’s most recently completed second quarter, may be deemed to have beneficially owned more than 10% of the voting
stock have been excluded. This determination of affiliate status is not necessarily a conclusive determination of affiliate status for
any other purpose.
The
number of shares outstanding of Registrant's common stock as of March 23, 2023 was 23,817,505.
NETWORK-1
TECHNOLOGIES, INC.
2022
FORM 10-K
TABLE
OF CONTENTS
Page
No.
PART
I
PART
I
Forward-looking
statements:
THIS
ANNUAL REPORT ON FORM 10-K CONTAINS STATEMENTS ABOUT FUTURE EVENTS AND EXPECTATIONS WHICH ARE “FORWARD-LOOKING STATEMENTS”.
ANY STATEMENT IN THIS 10-K THAT IS NOT A STATEMENT OF HISTORICAL FACT MAY BE DEEMED TO BE A FORWARD-LOOKING STATEMENT WITHIN THE MEANING
OF SECTION 27A OF THE SECURITIES EXCHANGE ACT OF 1933, AS AMENDED, OR SECTION 21E OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. FORWARD-LOOKING
STATEMENTS PROVIDE CURRENT EXPECTATIONS OF FUTURE EVENTS BASED ON CERTAIN ASSUMPTIONS AND INCLUDE ANY STATEMENT THAT DOES NOT DIRECTLY
RELATE TO ANY HISTORICAL OR CURRENT FACT. STATEMENTS CONTAINING SUCH WORDS AS “MAY,” “WILL,” “EXPECT,”
“BELIEVE,” “ANTICIPATE,” “INTEND,” “COULD,” “ESTIMATE,” “CONTINUE”
OR “PLAN” AND SIMILAR EXPRESSIONS OR VARIATIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS. THESE STATEMENTS
ARE BASED ON THE BELIEFS AND ASSUMPTIONS OF OUR MANAGEMENT BASED ON INFORMATION CURRENTLY AVAILABLE TO MANAGEMENT. SUCH FORWARD-LOOKING
STATEMENTS ARE SUBJECT TO CURRENT RISKS, UNCERTAINTIES AND ASSUMPTIONS RELATED TO VARIOUS FACTORS SET FORTH IN THIS REPORT AND IN OTHER
FILINGS MADE BY US WITH THE SECURITIES AND EXCHANGE COMMISSION. BASED UPON CHANGING CONDITIONS, SHOULD ANY ONE OR MORE OF THESE RISKS
OR UNCERTAINTIES MATERIALIZE, INCLUDING THOSE DISCUSSED AS “RISK FACTORS” IN ITEM 1A AND ELSEWHERE IN THIS REPORT, OR SHOULD
ANY OF OUR UNDERLYING ASSUMPTIONS PROVE INCORRECT, ACTUAL RESULTS MAY VARY MATERIALLY FROM THOSE DESCRIBED IN THIS REPORT. WE UNDERTAKE
NO OBLIGATION TO UPDATE, AND WE DO NOT HAVE A POLICY OF UPDATING OR REVISING THESE FORWARD-LOOKING STATEMENTS. READERS ARE CAUTIONED
NOT TO PLACE UNDUE RELIANCE ON FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE THE STATEMENT WAS MADE. UNLESS THE CONTEXT
OTHERWISE REQUIRES, THE TERMS “NETWORK-1,” “COMPANY,” “WE,” “OUR,” “US” MEAN
NETWORK-1 TECHNOLOGIES, INC. AND ITS WHOLLY-OWNED SUBSIDIARIES, MIRROR WORLDS TECHNOLOGIES, LLC AND HFT SOLUTIONS, LLC.
ITEM
1. BUSINESS
Overview
Our
principal business is the development, licensing and protection of our intellectual property assets. We presently own ninety-seven (97)
U.S. patents, fifty-two (52) of such patents have expired, and eight foreign patents relating to (i) our Cox patent portfolio (the “Cox
Patent Portfolio”) relating to enabling technology for identifying media content on the Internet and taking further actions to
be performed after such identification; (ii) our M2M/IoT patent portfolio (the “M2M/IoT Patent Portfolio”) relating to, among
other
things,
enabling technology for authenticating, provisioning and using embedded Sim (Subscriber Identification Module) technology in next generation
IoT, Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers; (iii) our HFT patent portfolio (the
“HFT Patent Portfolio”) covering certain advanced technologies relating to high frequency trading, which inventions specifically
address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference
between success and failure may be measured in nanoseconds; (iv) our Mirror Worlds patent portfolio (the “Mirror Worlds Patent
Portfolio”) relating to foundational technologies that enable unified search and indexing, displaying and archiving of documents
in a computer system; and (v) our remote power patent (the “Remote Power Patent”) covering the delivery of Power over Ethernet
(PoE) cables for the purpose of remotely powering network devices, such as wireless access ports, IP phones and network based cameras. In
addition, we review opportunities to acquire or license additional intellectual property as well as other strategic alternatives.
We
have invested $7,000,000 in ILiAD Biotechnologies, LLC (“ILiAD”), a clinical stage biotechnology company with an exclusive
license to sixty-four (64) patents. On December 31, 2022, we owned approximately 6.8% of the outstanding units of ILiAD on a non-fully
diluted basis and 6.3% of the outstanding units on a fully diluted basis (after giving effect to the exercise of all outstanding options
and warrants).
Our
current strategy includes continuing our efforts to monetize our intellectual property. In addition, we continue to seek to
acquire additional intellectual property assets to develop, commercialize, license or otherwise monetize. Our strategy includes working
with inventors and patent owners to assist in the development and monetization of their patented technologies. Our patent acquisition
and development strategy is to focus on acquiring high quality patents which management believes have the potential to generate significant
licensing opportunities as we have achieved with respect to our Remote Power Patent and our Mirror Worlds Patent Portfolio. In addition,
we may also enter into strategic relationships with third parties to develop, commercialize, license or otherwise monetize their intellectual
property.
We
have been dependent upon our Remote Power Patent for a significant portion of our revenue. We no longer receive licensing revenue for
our Remote Power Patent for any period subsequent to March 7, 2020 (the expiration date of the patent). Our future revenue is largely
dependent on our ability to monetize our other patent assets.
We
have pending litigation involving our assertion of infringement claims concerning certain patents within our Cox Patent Portfolio and
our Remote Power Patent. In addition, we have a pending appeal to the U.S. Court of Appeals for the Federal Circuit of the District Court
judgment of non-infringement dismissing our case against Meta Platforms, Inc. (formerly Facebook, Inc.) involving certain patents within
our Mirror Worlds Patent Portfolio (see “Legal Proceedings” at pages 19-21 of this Annual Report).
At
December 31, 2022, we had cash and cash equivalents and marketable securities of $48,439,000 and working capital of $47,359,000. Based
on our current cash position, we believe that we will have sufficient cash to fund our operations for the foreseeable future.
Overview
of Our Patents
We
currently own ninety-seven (97) U.S. patents and eight foreign patents relating to patents within our Cox Patent Portfolio, M2M/IoT Patent
Portfolio, HFT Patent Portfolio, Mirror World Patent Portfolio and our Remote Power Patent. With respect to our ninety-seven (97) U.S.
patents, fifty-two (52) of such patents have expired. However, we can assert expired patents against third parties but only for past
damages up to the expiration date. We currently have pending litigation involving expired patents including our Remote Power Patent,
and certain patents within our Cox and Mirror Worlds Patent Portfolios (see “Legal Proceedings” at pages 19-21 hereof).
Cox
Patent Portfolio
Our
Cox Patent Portfolio, acquired from Dr. Ingemar Cox in February 2013, currently consists of thirty-nine (39) U.S. patents relating to
enabling technology for identifying media content on the Internet, such as audio and video, and taking further actions to be performed
based on such identification. All of the patents within our Cox patent portfolio expired in September 2021 except for two patents which
expire in July 2023 and November 2023. We have pending litigation against Google Inc. and YouTube, LLC involving assertion of certain
patents within our Cox Patent Portfolio (see “Legal Proceedings” at page 19 hereof). The patents within our Cox Patent Portfolio
are based on a patent application filed in 2000. Since the acquisition of the Cox Patent Portfolio in February 2013, we have been issued
thirty-four (34) additional patents relating to this portfolio. The claims in these thirty-four (34) additional patents are generally
directed towards systems of content identification and performing actions following therefrom.
We
are obligated to pay Dr. Cox 12.5% of the net proceeds generated by us from licensing, sale or enforcement of the Cox Patent Portfolio.
Dr. Cox provides consulting services to us with respect to the Cox Patent Portfolio and assists our efforts to develop the patent portfolio.
Dr.
Cox is currently a Professor at the University of Copenhagen and University College London where he is head of its Information and Decision
Systems Group. Dr. Cox was formerly a member of the Technical Staff at AT&T Bell Labs and a Fellow at NEC Research Institute. He
is a Fellow of the ACM, IEEE, the IET (formerly IEE), and the British Computer Society and is a member of the UK Computing Research Committee.
In 2019, Dr. Cox was the recipient of the Tony Kent Strix Award in recognition of his contribution to the field of information retrieval.
He was founding co-editor in chief of the IEE Proc. on Information Security and was an associate editor of the IEEE Trans. on Information
Forensics and Security. He is co-author of a book entitled “Digital Watermarking” and its second edition “Digital Watermarking
and Steganography”. He is an inventor or co-inventor of over seventy (70) U.S. patents.
M2M/IoT
Patent Portfolio
Our
M2M/IoT Patent Portfolio, acquired in December 2017 from M2M and IoT Technologies, LLC (“M2M”), relates to, among other things,
enabling technology for authenticating, provisioning and using embedded SIM technology in next generation IoT, Machine-to-Machine and
other mobile devices including smartphones, tablets and computers as well as automobiles and drones. The M2M/IoT Patent Portfolio currently
consists of thirty-four (34) issued U.S. patents, four pending U.S. patent applications, seven registered foreign patents and seven additional
pending non-U.S. patent applications. Since we acquired the M2M/IoT Patent Portfolio in December 2017, we have been issued twenty-two
(22) additional U.S. patents with respect to the portfolio. We anticipate further issuances of additional claims for this portfolio.
The expiration dates of the thirty-four (34) issued U.S. patents currently within our M2M/IoT Patent Portfolio range from September 2033
to May 2034.
We
have an obligation to pay M2M 14% of the first $100 million of net proceeds (after deduction of expenses) and 5% of net proceeds greater
than $100 million from Monetization Activities (as defined) related to our M2M/IoT Patent Portfolio. In addition, M2M will be entitled
to receive from us $250,000 of additional consideration upon the occurrence of certain future events related to the patent portfolio.
John
Nix, the Managing Member of M2M, provides consulting services to us with respect to our M2M/IoT Patent Portfolio. Mr. Nix is an entrepreneur
and inventor, and founder and Chief Executive Officer of Vobal Technologies, LLC. In 2016, Mr. Nix was recognized as “Creator of
the Year” by the Intellectual Property Law Association of Chicago for his intellectual property related to embedded SIM technology.
HFT
Patent Portfolio
On
March 25, 2022, we acquired the HFT Patent Portfolio. This portfolio covers certain advanced technologies relating to high frequency
trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency
gains in trading systems where the difference between success and failure may be measured in nanoseconds. The HFT Patent Portfolio
currently includes nine issued U.S. patents and two pending U.S. patents.
In
addition to the purchase price that we paid at closing, we have an obligation to pay the seller an additional cash payment of $500,000
and $375,000 of our common stock contingent upon achieving certain milestones with respect to the HFT Patent Portfolio. We also have
an obligation to pay the seller 15% of the first $50 million of net proceeds (after deduction of expenses) generated from the patent
portfolio and 17.5% of net proceeds greater than $50 million.
Mirror
Worlds Patent Portfolio
Our
Mirror Worlds Patent Portfolio, acquired in May 2013, consists of ten (10) U.S. patents and covers foundational technologies that enable
unified search and indexing, displaying and archiving of documents in a computer system. All of our patents within our Mirror Worlds
Patent Portfolio have expired. The Mirror Worlds Patent Portfolio includes U.S. Patent No. 6,006,227 (the “227 Patent”),
U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 which are currently being asserted in our litigation against Meta Platforms,
Inc. (formerly Facebook, Inc.) (see “Legal Proceedings” at pages 19-20 hereof). Our 227 Patent was previously asserted in
litigations against Apple Inc. and Microsoft Corporation which were settled resulting in aggregate payments to us of $29,650,000.
The
inventions relating to document stream operating systems covered by our Mirror Worlds Patent Portfolio resulted from the work done by
Yale University computer scientist, Professor David Gelernter, and his then graduate student, Dr. Eric Freeman, in the mid-1990s. Certain
aspects of the technologies developed by David Gelernter were commercialized in their company's product offering called “Scopeware.”
Technologies embodied in Scopeware are now common in various computer and web-based operating systems. Professor Gelernter and Dr. Freeman
each entered into consulting agreements with us as part of our acquisition of the Mirror Worlds Patent Portfolio.
As
part of our acquisition of the Mirror Worlds Patent Portfolio in 2013, we also entered into an agreement with Recognition Interface,
LLC (“Recognition”), an entity that financed the commercialization of the Mirror Worlds patent portfolio prior to its sale
to Mirror Worlds, LLC and also retained an interest in the licensing proceeds of the Mirror Worlds patent portfolio. Pursuant to the
terms of the agreement with us, we are obligated to pay Recognition an interest in the net proceeds realized from our monetization of
the Mirror Worlds Patent Portfolio as follows: (i) 10% of the first $125 million of net proceeds; (ii) 15% of the next $125 million of
net proceeds; and (iii) 20% of any portion of the net proceeds in excess of $250 million. Since entering into the agreement with Recognition
in May 2013, we have paid Recognition an aggregate of $3,127,000 with respect to such net proceeds interest in our Mirror Worlds Patent
Portfolio (no such payments were made during the years 2022 and 2021).
Remote
Power Patent
Our
Remote Power Patent (U.S. Patent No. 6,218,930) covers the delivery of power over Ethernet cables for the purpose of remotely powering
network devices such as wireless access ports, IP phones and network based cameras. Our Remote Power Patent expired on March 7, 2020.
Notwithstanding the expiration of the Remote Power Patent in March 2020, we are currently asserting the patent in separate actions against
five defendants for damages prior to March 7, 2020 (expiration date) (see “Legal Proceedings” at page 20 hereof).
On
June 13, 2003, the Institute of Electrical Engineers (IEEE), a non-profit, technical professional association, approved the 802.3af Power
over Ethernet standard (the “Standard”), which covers technologies deployed in delivering power over Ethernet networks. The
Standard provides for the Power Sourcing Equipment (PSE) to be deployed in switches or as standalone midspan hubs to provide power to
remote devices such as wireless access points, IP phones and network-based cameras. The technology is commonly referred to as Power over
Ethernet (“PoE”). In 2009, the IEEE Standards Association approved 802.3at, a new PoE standard which, among other things,
increased the available power for delivery over Ethernet networks. We believe that our Remote Power Patent covers several of the key
technologies covered by both the 802.3af and 802.3at standards.
Network-1
Strategy
Our
strategy is to capitalize on our intellectual property assets by entering into licensing arrangements with third parties that utilize
our intellectual property's proprietary technologies as well as any additional proprietary technologies covered by patents which may
be acquired by us in the future. Our current patent acquisition and development strategy is to focus on acquiring high quality patents
which management believes have the potential to generate significant licensing opportunities as has been the case with our Remote Power
Patent and Mirror Worlds Patent Portfolio. Our Remote Power Patent has generated licensing revenue in excess of $187,000,000 from May
2007 through December 31, 2022. Since acquisition of our Mirror Worlds Patent Portfolio in May 2013, we have received licensing and other
revenue of $47,150,000 through December 31, 2022. In addition, we may enter into third party strategic relationships with inventors and
patent owners to assist in the development and monetization of their patent technologies. Based on our cash position, we review opportunities
to acquire additional intellectual property as well as evaluate other strategic alternatives.
In
connection with our activities relating to the protection of our intellectual property assets, or the intellectual property assets of
third parties with whom we may have strategic relationships in the future, it may be necessary to assert patent infringement claims against
third parties whom we believe are infringing our patents or those of our strategic partners. We are currently involved in several litigations
to protect our patents including certain patents within our Cox Patent Portfolio, Mirror Worlds Patent Portfolio and Remote Power Patent
(see “Legal Proceedings” at pages 19-21 hereof). We have previously successfully asserted litigation with respect to our
Remote Power Patent and our Mirror Worlds Patent Portfolio and have also been successful in defending proceedings at the USPTO challenging
the validity of our Remote Power Patent and certain patents within our Cox Patent Portfolio.
Significant
Licensees
We
had no revenue for the year ended December 31, 2022. Revenue from our Remote Power Patent constituted 100% of our revenue for the year
ended December 31, 2021, of which two licensees constituted 99% of our revenue for such year.
Competition
With
respect to our ability to acquire additional intellectual property assets or enter into strategic relationships with third parties to
monetize their intellectual property assets, we face considerable competition from other companies, many of which have significantly
greater financial and other resources than we have. The patent licensing and enforcement industry has grown and there has been a material
increase in the number of companies seeking to acquire intellectual property assets from third parties or to provide financing to third
parties seeking to monetize their intellectual property. Entities including, among others, Acacia Research Corporation (NASDAQ:ACTG),
Intellectual Ventures, WI-LAN Inc., a subsidiary of Quarterhill Inc. (NASDAQ:QTRH), VirnetX Holdings Corporation (NYSE MKT:VHC) and
RPX Corporation, seek to acquire intellectual property or partner with third parties to license or enforce intellectual property rights. In
addition, we also compete with strategic corporate buyers with respect to the acquisition of intellectual property assets. It is expected
that others will enter this market as well. Many of these competitors have significantly greater financial and human resources than us.
We
may also compete with litigation funding firms such as Burford Capital Limited, Validity Finance, LLC, Fortress Investment Group, LLC,
Parabellum Capital LLC and Bentham Capital LLC, venture capital firms and hedge funds for intellectual property acquisitions and licensing
opportunities. Many of these competitors also have greater financial resources and human resources than us.
Regulatory
Environment
If
new legislation, regulations or rules are implemented either by Congress, the USPTO or the courts that impact the patent application
process, the patent enforcement process or the rights of patent holders, these changes could negatively affect our business, financial
condition and results of operations. Certain legislation, regulations, and rulings by the courts and actions by the USPTO have materially
increased the risk and cost of enforcement of patents. U.S. patent laws were amended by the Leahy-Smith America Invents Act, referred
to as the “America Invents Act”, which became effective on March 16, 2013. The America Invents Act included a number of significant
changes to U.S. patent law. In general, it addressed issues surrounding the enforceability of patents and the increase in patent litigation
by, among other things, establishing new procedures for patent litigation and new administrative post-grant review procedures to challenge
the patentability of issued patents outside of litigation, including Inter Partes Review (IPR) and Covered Business Method
Review (CBM) proceedings which provide third parties a timely and cost effective alternative to district court litigation to challenge
the validity of an issued patent. The America Invents Act and its implementation has increased the uncertainties and costs surrounding
the enforcement of patent rights has made it more difficult to successfully enforce our patents.
In
addition, future changes in patent law could adversely impact our business. Such changes may not be advantageous to us and may make it
more difficult to obtain adequate patent protection to enforce our patents. Increased focus on the growing number of patent lawsuits,
particularly by non-practicing entities (NPEs), may result in legislative changes which increase the risk and costs of asserting patent
litigation.
Investment
in ILiAD Biotechnologies
During
the period December 2018 to date, we made an aggregate investment of $7,000,000 in ILiAD, a privately held clinical stage biotechnology
company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis. ILiAD is currently focused
on validating its proprietary intranasal vaccine, BPZE1, for the prevention of pertussis (whooping cough). Pertussis is a life-threatening
disease caused by the highly contagious respiratory bacterium Bordetella pertussis. According to the U.S. Centers for Disease
Control and Prevention, each year pertussis affects approximately 16 million people globally, accounting for nearly 200,000 deaths. ILiAD
has the exclusive license to sixty-four (64) issued patents and has thirty (30) pending patent applications. On December 31, 2022, we
owned approximately 6.8% of the outstanding units of ILiAD on a non-fully diluted basis and 6.3% of the outstanding units on a fully
diluted basis (after giving effect to the exercise of all outstanding options, and warrants). In connection with our investment, Corey
Horowitz, our Chairman and Chief Executive Officer, became a member of ILiAD’s Board of Managers.
BPZE1
was developed in the laboratory of Camille Locht, PhD, at the Institut Pasteur de Lille (IPL) and French National Institute of Health
and Medical research. BPZE1 is a live-attenuated intranasal vaccine designed to overcome deficiencies of current pertussis vaccines,
including poor durability of protection and failure to prevent nasopharyngeal Bordetella pertussis infections that lead to escape
mutants and transmission to vulnerable infants. On January 3, 2022, ILiAD announced that the U.S. Food and Drug Administration (FDA)
granted Fast Track designation for BPZE1.
On
August 24, 2022, ILiAD consummated a private financing of $42,800,000 of its Class D units, of which a multi-national pharmaceutical
company invested $30,000,000. As a result of the financing, we recognized a gain of $3,883,000 on our equity investment and a gain of
$271,000 with respect to the conversion of our convertible note in the principal amount of $1,000,000 plus interest into equity of ILiAD.
Corporate
Information
We
were incorporated under the laws of the State of Delaware in July 1990. Our principal executive offices are located at 65 Locust Avenue,
Third Floor, New Canaan, Connecticut 06840 and our telephone number is (203) 920-1055.
Available
Information
We
file or furnish various reports, such as registration statements, quarterly and current reports, proxy statements and other materials
with the SEC. Our website address is www.network-1.com. You may obtain, free of charge on our Internet website, copies
of our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements and amendments to those
reports or statements filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as reasonably practicable after
we electronically file such material with, or furnish it to, the SEC. The information we post on our website is intended for reference
purposes only; none of the information posted on our website is part of this Annual Report or incorporated by reference herein.
In
addition to the materials that are posted on our website, you may read and copy any materials we file with the SEC at the SEC's Public
Reference Room at 100 F Street, NE, Washington, DC 20549. You may obtain information on the operation of the Public Reference Room by
calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet site that contains reports, proxy and other information statements,
and other information regarding issuers, including us, that file electronically with the SEC. The address of the SEC’s Internet
site is http://www.sec.gov.
Employees
and Consultants
We
currently have two employees and two consultants providing monthly services to us.
ITEM
1A. RISK FACTORS
Our
operations and financial results are subject to various material risks and uncertainties, including those described below, which could
adversely affect our business, financial condition, results of operations, cash flow, and the trading price of our common stock. You
should carefully consider the material risks and uncertainties described below in addition to the other information set forth in this
Annual Report on Form 10-K, including, but not limited to, the section titled “Management’s Discussion and Analysis of Financial
Condition and Results of Operations.” The material risks described below are not the only risks we face. Additional risks that
we do not know of or that we currently believe are immaterial may also impair our business operations. If any of the following risks
actually occur, our business, financial condition, results of operations and cash flow could be materially adversely affected, and the
trading price of our common stock could decline significantly.
Risks
Related to Our Business
Our
revenue from licensing intellectual property is uncertain as it is generally dependent upon litigation outcomes involving our patents
which we cannot predict.
Our
revenue is dependent upon our litigation outcomes. We currently have pending litigation involving our Cox Patent Portfolio and Mirror
Worlds Patent Portfolio as well as our Remote Power Patent (see “Legal Proceedings” at pages 19-21 hereof). Patent litigation
is inherently risky and uncertain and we cannot assure you that any of our current or future litigation will result in a favorable outcome
for us. Accordingly, our revenue is uncertain.
If
we are unable to protect our patents, our business would be negatively impacted.
We
believe our patents are valid, enforceable and valuable. Despite this belief, third parties typically defend assertion of our patents
by asserting defenses, among others, of non-infringement and invalidity. In addition, in the future certain of our patents may be subject
to USPTO post-grant inter partes review proceedings (IPRs) which could result in all or a part of our patents being invalidated
or the claims being limited. Unfavorable outcomes in our litigation or IPRs may reduce our ability to enforce our patents or have other
adverse consequences. If we are unable to protect our patents or otherwise realize value for them, our business would be negatively impacted.
The
outcome of our substantial investment in ILiAD is uncertain.
To
date we have invested $7,000,000 in ILiAD, a privately held clinical stage biotechnology company, with focus on validating its proprietary
intranasal vaccine (BPZE1) for the prevention of pertussis (whopping cough). For the year ended December 31, 2022, we recorded a gain
of $3,883,000 on our ILiAD investment in accordance with Accounting Standards Codification (ASC) 323 as a result of ILiAD’s completion
of a private financing of approximately $42,800,000 in August 2022 which included an investment of $30,000,000 by a multi-national pharmaceutical
company. We also recorded a gain in 2022 of $271,000 in connection with conversion of our convertible note in the principal amount of
$1,000,000 plus accrued interest into equity in the ILiAD private offering (see Note B[6] and Note H to our consolidated financial statements
included herein). Notwithstanding the gains we recorded in 2022, our investment in ILiAD remains subject to substantial risks.
We
have been dependent upon our Remote Power Patent for a significant portion of our revenue and we may not be able to generate future revenue
from our other patents.
Our
Remote Power Patent has generated licensing revenue for us in excess of $187,000,000 from May 2007 through December 31, 2022. We had
no revenue in 2022 and revenue from our Remote Power Patent constituted 100% of our revenue for 2021 ($36,029,000), 2020 ($4,403,000)
and 2019 ($3,037,000). As a result of the expiration of our Remote Power Patent on March 7, 2020, we no longer receive licensing revenue
from such patent for any period subsequent to the expiration date. Our failure to successfully monetize our other patents would have
a negative impact on our business, financial condition and operating results.
We
may not achieve successful outcomes of our pending or future litigation which would have a negative impact on our business.
We
are currently enforcing certain patents within our Cox Patent Portfolio against Google and YouTube, who are challenging these patents
and we are also asserting our Remote Power Patent in nine separate litigations against ten defendants. We have appealed to the Federal
Circuit the District Court decision granting Facebook (Meta Platforms, Inc.), summary judgment of non-infringement and dismissing
our case involving certain patents within our Mirror Worlds Patent Portfolio (see “Legal Proceedings” at pages 19-20 hereof).
In addition, our M2M/IoT Patent Portfolio and HFT Patent Portfolio, are not currently being asserted. We may not have success in enforcing
or defending our patents, which would have a negative impact on our business.
We
may not be able to capitalize in the future on our strategy to acquire high quality patents with significant licensing opportunities
or enter into strategic relationships with third parties to license or otherwise monetize their intellectual property.
Based
upon the success we achieved from licensing our Remote Power Patent (twenty-eight (28) license agreements which generated in excess of
$187,000,000 of revenue), the revenue we generated from our Mirror Worlds Patent Portfolio ($47,150,000) and establishing a patent portfolio
currently consisting of ninety-seven (97) U.S. patents and eight foreign patents as well as our cash position, we believe we have the
expertise and sufficient capital to compete in the patent monetization market and to enter strategic relationships with third parties
to develop, commercialize, license or otherwise monetize their patents. Our strategy is to focus on acquiring high quality patent assets
which management believes have the potential for significant licensing opportunities. However, we may not be able to acquire such additional
high quality patents or, if acquired, we may not achieve material revenue or profit from such patents. Acquisitions of patent assets
are competitive, time consuming, complex and costly to consummate. High quality patents with significant licensing opportunities
are difficult to find and are often very competitive to acquire. In addition, such acquisitions present material risks. Even
if we acquire such additional patent assets, we may not be able to achieve significant licensing revenue or even generate sufficient
revenue related to such patent assets to offset the acquisition costs and the legal fees and expenses which may be incurred to enforce,
license or otherwise monetize such patents. In addition, we may not be able to enter into strategic relationships with third parties
to license or otherwise monetize their intellectual property and, even if we consummate such strategic relationships, we may not achieve
material revenue or profit from such relationships.
The
patent monetization cycle is long, costly and unpredictable.
There
is generally a significant time lag between acquiring a patent portfolio and recognizing revenue from those patent assets. During this
time lag, significant costs are likely to be incurred which may have a negative impact on our results of operations, cash flow and financial
position. Furthermore, the outcome of our efforts to monetize our patents is uncertain and we may not be successful.
Our
quarterly and annual operating and financial results and our revenue are difficult to predict and are likely to fluctuate significantly
in future periods.
Our
quarterly and annual operating and financial results are difficult to predict and may fluctuate significantly from period to period.
In 2022, we had no revenue and incurred a net loss of $2,326,000. We had revenue of $36,029,000 and net income of $14,281,000 for 2021,
as compared to revenue of $4,403,000 and a net loss of $1,709,000 for 2020. We had revenue of $3,037,000 and a net loss of $1,792,000
for 2019 as compared to revenue and net income of $22,106,000 and $7,706,000 for 2018. Accordingly, our revenue, net income and results
of operations may widely fluctuate as a result of a variety of factors that are outside our control including the timing and our ability
to achieve successful outcomes from current and future patent litigation, our ability and timing in consummating future license agreements
for our intellectual property assets, the timing and extent of payments received by us from licensees, whether we will achieve a successful
outcome of our investment in ILiAD, and the timing and our ability to achieve revenue from future strategic relationships.
In
the future we could be classified as a Personal Holding Company resulting in a 20% tax on our PHC Income that we do not distribute to
our shareholders.
The
personal holding company (“PHC”) rules under the Internal Revenue Code impose a 20% tax on a PHC’s undistributed personal
holding company income (“UPHCI”), which means, in general, taxable income subject to certain adjustments and reduced by certain
distributions to shareholders. For a corporation to be classified as a PHC, it must satisfy two tests: (1) that more than 50% in value
of its outstanding shares must be owned directly or indirectly by five or fewer individuals at any time during the second half of the
year (after applying constructive ownership rules to attribute stock owned by entities to their beneficial owners and among certain family
members and other related parties) (the “Ownership Test”) and (2) at least 60% of its adjusted ordinary gross income for
a taxable year consists of dividends, interest, royalties, annuities and rents (the “Income Test”). During the second
half of 2022, based on available information concerning our shareholder ownership, we did not satisfy the Ownership Test and thus we
were not a PHC for 2022. However, we may be determined to be a PHC in the future. If we were determined to be a PHC in 2023
or any future year, we would be subject to an additional 20% tax on our UPHCI. In such event, we may issue a special cash dividend to
our shareholders in an amount equal to the UPHCI rather than incur the 20% tax.
We
are dependent upon our CEO and Chairman.
Our
success is largely dependent upon the personal efforts of Corey M. Horowitz, our Chairman, Chief Executive Officer and Chairman of our
Board of Directors. On March 22, 2022, we entered into a new four year employment agreement with Mr. Horowitz pursuant to which
he continues to serve as our Chairman and Chief Executive Officer. The loss of the services of Mr. Horowitz would have a material adverse
effect on our business and prospects. We do not maintain key-man life insurance on the life of Mr. Horowitz.
Cash
dividends may not be continued to be paid.
Our
dividend policy consists of semi-annual cash dividends of $0.05 per share ($0.10 per share annually) which have been paid in March and
September of each year. We have paid such semi-annual dividends since our dividend policy was enacted in December 2016. At this
time we anticipate continuing to pay dividends consistent with our policy. However, our dividend policy undergoes a periodic review by
our Board of Directors and is subject to change at any time depending upon our earnings, financial requirements and other factors existing
at the time. We may not be in a position to continue to pay dividends in the future.
Legislation,
regulations, court rulings and actions by the USPTO have materially increased the risk and cost of enforcement of patents and may continue
to do so in the future.
Legislation,
regulations, court rulings and actions by the USPTO have materially increased the risk and cost of enforcing patents. U.S. patent laws
were amended by the Leahy-Smith America Invents Act, referred to as the America Invents Act, which became effective on March 16, 2013.
The America Invents Act included a number of significant changes to U.S. patent law. In general, it addressed issues surrounding the
enforceability of patents and the increase in patent litigation by, among other things, established new procedures for patent litigation
and new administrative post-grant review procedures to challenge the patentability of issued patents outside of litigation, including
Inter Partes Review (IPR) and Covered Business Method Review (CBM) proceedings which provide third parties a timely, cost
effective alternative to district court litigation to challenge the validity of an issued patent. In addition, the America Invents Act
changed the way that parties may be joined in patent infringement actions, and increased the likelihood that such actions will need to
be brought against individual parties allegedly infringing by their respective individual actions or activities. The America Invents
Act and its implementation also increased the uncertainties and costs surrounding the enforcement of patent rights, which could have
a material adverse effect on our business, financial condition and results of operations.
Changes
in patent law could adversely impact our business.
Patent
laws may continue to change and may alter the protections afforded to owners of patent rights. Such changes may not be advantageous to
us and may make it more difficult to obtain adequate patent protection to enforce our patents. Increased focus on the growing number
of patent lawsuits, particularly by non-practicing entities (NPEs), may result in further legislative changes which increase the risk
and costs of asserting patent litigation.
Our
pending patent infringement litigations are time consuming and costly.
We
have pending litigations involving our Cox Patent Portfolio, Mirror Worlds Patent Portfolio (pending appeal to the Federal Circuit of
dismissal of our Facebook (Meta Platforms, Inc.) litigation) and Remote Power Patent (see “Legal Proceedings” at pages 19-21
of this Annual Report). While we have contingent legal fee arrangements, or a contingency plus a fixed cash amount arrangement, with
our patent litigation counsel in each litigation, we are responsible for all or a portion of the expenses which are anticipated to be
material. In addition, the time and effort required of our management to effectively pursue these litigations is likely to be significant
and it may adversely affect other business opportunities.
We
face intense competition to acquire intellectual property and enter into strategic relationships.
With
respect to our ability to acquire additional intellectual property or enter into strategic relationships with third parties to monetize
their intellectual property, we face considerable competition from other companies, many of which have significantly greater financial
and other resources than we have. We face a number of competitors in the patent licensing and enforcement business seeking to acquire
intellectual property rights from third parties. Many of these competitors have significantly more financial and human resources than
us.
We
may also compete with strategic corporate buyers, litigation funding firms, venture capital firms and hedge funds for intellectual property
acquisitions and licensing opportunities. Many of these competitors have greater financial resources and human resources than us.
Our
markets are subject to rapid technological change and our technologies face potential technology obsolescence.
The
markets covered by our intellectual property are characterized by rapid technological changes, changing customer requirements, frequent
new product introductions and enhancements, and evolving industry standards. The introduction of products embodying new technologies
and the emergence of new industry standards may render our technologies obsolete or less marketable.
In
addition, other companies may develop competing technologies that offer better or less expensive alternatives to the technologies covered
by our intellectual property. Moreover, technological advances or entirely different approaches developed by other companies or adopted
by various standards groups could render our patents obsolete, less marketable or unenforceable.
The
burdens of being a public company may adversely affect us including our ability to pursue litigation.
As
a public company, our management must devote substantial time, attention and financial resources to comply with U.S. securities laws.
This may have a material adverse effect on management's ability to effectively and efficiently pursue its business. In addition, our
disclosure obligations under U.S. securities laws require us to disclose information publicly that will be available to litigation opponents.
We may, from time to time, be required to disclose information that may have a material adverse effect on our litigation strategies.
This information may enable our litigation opponents to develop effective litigation strategies that are contrary to our interests.
General
Risk Factors
Investors
may have limited influence on stockholder decisions because ownership of our common stock is concentrated.
As
of March 10, 2023, our executive officers and directors beneficially owned 30.8% of our outstanding common stock. As a result, these
stockholders may be able to exercise substantial control over all matters requiring stockholder approval, including the election of directors
and approval of significant corporate transactions, such as a merger or other sale of our company or its assets. This concentration of
ownership will limit other stockholders' ability to influence corporate matters and may have the effect of delaying or preventing a third
party from acquiring control over us.
Our
common stock may be delisted from the NYSE American exchange if we fail to comply with continued listing standards.
Our
common stock is currently traded on the NYSE American exchange under the symbol “NTIP”. If we fail to meet any of the continued
listing standards of the NYSE American exchange, our common stock could be delisted. Such delisting could adversely affect the price
and trading (including liquidity) of our common stock.
There
are inherent uncertainties involved in estimates, judgments and assumptions used in the preparation of financial statements in accordance
with U.S. GAAP. Any changes in estimates, judgments and assumptions could have a material adverse effect on our business, financial condition,
and operating results.
The
preparation of financial statements in accordance with accounting principles generally accepted in the Unites States (“U.S. GAAP”)
involves making estimates, judgments and assumptions that affect reported amounts of assets (including intangible assets), liabilities
and related reserves, revenues, expenses, and income. Estimates, judgments, and assumptions are inherently subject to change in the future,
and any such changes could result in corresponding changes to the amounts of assets, liabilities, expenses, and income. Any such changes
could have a material adverse effect on our business, financial condition, and operating results.
Provisions
in our corporate charter, by-laws and in Delaware law could make it more difficult for a third party to acquire us, discourage a takeover
and adversely affect existing stockholders.
Our
certificate of incorporation authorizes the Board of Directors to issue up to 10,000,000 shares of preferred stock. The preferred
stock may be issued in one or more series, the terms of which may be determined at the time of issuance by our Board of Directors, without
further action by stockholders, and may include, among other things, voting rights (including the right to vote as a series on particular
matters), preferences as to dividends and liquidation, conversion and redemption rights, and sinking fund provisions, any of which could
adversely affect holders of our common stock. Although there are currently no shares of preferred stock outstanding, future holders of
preferred stock may have rights superior to our common stock and such rights could also be used to restrict our ability to merge with
or sell our assets to third parties.
We
are also subject to the “anti takeover” provisions of Section 203 of the Delaware General Corporation Law, which could prevent
us from engaging in a “business combination” with a 15% or greater stockholder for a period of three years from the date
such person acquired that status unless appropriate board or stockholder approvals are obtained.
In
addition, our By-laws contain advance notice requirements for director nominations and for new business to be brought up at stockholder
meetings. Stockholders wishing to submit director nominations or raise matters to a vote of stockholders must provide notice to us within
specified date windows and in very specific forms in order to have that matter voted on at a stockholders meeting.
The
aforementioned provisions could deter unsolicited takeovers or delay or prevent changes in our control or management, including transactions
in which stockholders might otherwise receive a premium for their shares over the then current market price. These provisions may also
limit the ability of stockholders to delay, deter or prevent a change of control, or approve transactions that they may deem to be in
their best interests.
Our
stock price may be volatile.
The
market price of our common stock may be highly volatile and could fluctuate widely in price in response to various factors, many of which
are beyond our control, including the following:
| • | the
outcome of our litigation against Google and YouTube involving certain patents within our
Cox Patent Portfolio; |
| • | our
ability to further develop, license and monetize our M2M/IoT Patent Portfolio; |
| • | our
ability to further develop, license and monetize our HFT Patent Portfolio; |
| • | our
ability to achieve a successful outcome of our investment in ILiAD; |
| • | the
outcome of our appeal to the Federal Circuit of the District Court ruling granting Facebook
summary judgment of non-infringement and dismissing our case involving certain patents
within our Mirror Worlds Patent Portfolio; |
| • | our
ability to acquire additional intellectual property; |
| • | our
ability to enter into strategic relationships with third parties to license or otherwise
monetize their intellectual property; |
| • | variations
in our quarterly and annual operating results; |
| • | our
ability to continue to pay cash dividends; |
| • | our
ability to raise capital if needed; |
| • | sales
of our common stock; |
| • | legislative,
regulatory and competitive developments; and |
| • | economic
and other external factors. |
In
addition, the securities markets have from time to time experienced significant price and volume fluctuations that are unrelated to the
operating performance of particular companies. These market fluctuations may also have a material and adverse effect on the market price
of our common stock.
ITEM
1B. UNRESOLVED STAFF COMMENTS
None.
ITEM
2. PROPERTIES
Our
principal executive offices are located in New Canaan, Connecticut, where we lease approximately 2,000 square feet of office space at
a base rent of $5,500 per month pursuant to a lease amendment, dated May 1, 2022, which term expires on April 30, 2025. We believe that
our office facility is suitable and appropriate to support our current needs.
ITEM 3. LEGAL PROCEEDINGS
Cox
Patent Portfolio Litigation
On
April 4, 2014 and December 3, 2014, we initiated litigation against Google Inc. (“Google”) and YouTube, LLC (“YouTube”)
in the U.S. District Court for the Southern District of New York for infringement of several of our patents within our Cox Patent Portfolio
which relate to the identification of media content on the Internet. The lawsuit alleges that Google and YouTube have infringed and continue
to infringe certain of our patents by making, using, selling and offering to sell unlicensed systems and related products and services,
which include YouTube’s Content ID system.
The
litigations against Google and YouTube were subject to court ordered stays which were in effect from July 2, 2015 until January 2, 2019
as a result of proceedings then pending at the Patent Trial and Appeal Board (PTAB) and the appeals to the U.S. District Court of Appeals
for the Federal Circuit. Pursuant to a joint stipulation and order, entered on January 2, 2019, the parties agreed, among other things,
that the stays with respect to the litigations were lifted. In January 2019, the two litigations against Google and YouTube were consolidated.
Discovery is complete and the parties have each submitted summary judgment motions. A trial date has not yet been set.
Mirror
Worlds Patent Portfolio Litigation
Meta
(Facebook) Litigation
On
May 9, 2017, Mirror Worlds Technologies, LLC, our wholly-owned subsidiary, initiated litigation against Facebook, Inc. (“now Meta
Platforms, Inc., “Meta”) in the U.S. District Court for the Southern District of New York, for infringement of U.S. Patent
No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 (among the patents within our Mirror Worlds Patent Portfolio).
The lawsuit alleges that the asserted patents are infringed by Meta’s core technologies that enable Meta’s Newsfeed and Timeline
features. We seek, among other things, monetary damages based upon reasonable royalties.
On
May 7, 2018, Meta filed a motion for summary judgment on non-infringement. On August 11, 2018, the Court issued an order granting Facebook’s
motion for summary judgment of non-infringement and dismissed the case. On January 23, 2020, the U.S. Court of Appeals for the
Federal Circuit ruled in our favor and reversed the summary judgment finding on non-infringement of the District Court and remanded the
litigation to the Southern District of New York for further proceedings.
On
March 7, 2022, the District Court entered a ruling granting in part and denying in part a motion for summary judgment by Meta. In its
ruling the Court (i) denied Meta’s motion that the asserted patents were invalid by concluding that all asserted claims were patent
eligible under §101 of the Patent Act and (ii) granted summary judgment of non-infringement in favor of Facebook and dismissed
the case. We strongly disagree with the decision on non-infringement and on April 4, 2022 we filed an appeal to the U.S. Court of
Appeals for the Federal Circuit. The appeal is pending.
Remote
Power Patent Litigation
October-November
2022 Litigation
In
October and November 2022, we initiated nine separate litigations against ten defendants for infringement of our Remote Power Patent
seeking monetary damages based upon reasonable royalties, as follows:
| • | On
October 6, 2022, we initiated such litigation against Arista Networks, Inc., Fortinet, Inc.,
Honeywell International Inc. and Ubiquiti Inc. in the United States District Court, District
of Delaware; |
| • | On
October 27, 2022, and November 3, 2022, we initiated such litigation against TP-Link USA
Corporation and Hikvision USA, Inc. in the United States District Court for the Central District
of California; |
| • | On
November 4, 2022, we initiated such litigation against Panasonic Holdings Corporation and
Panasonic Corporation of North America in the United States District Court for the Eastern
District of Texas (Marshall Division); and |
| • | On
November 8, 2022 and November 16, 2022, we initiated such litigation against Antaira Technologies,
LLC and Dahua Technology USA in the United States District Court for the Central District
of California. |
During
the period January 24, 2023 through March 10, 2023, we entered into settlement agreements with Arista Networks, Inc., Antaira Technologies,
LLC, Panasonic Holdings Corporation and TP-Link USA Corporation with respect to the above referenced litigations resulting in aggregate
settlement payments to us of $537,300 and a conditional payment of $150,000.
Netgear
Litigation
On
December 15, 2020, we filed a lawsuit against Netgear in the Supreme Court of the State of New York, County of New York, for breach of
a Settlement and License Agreement, dated May 22, 2009, with us for Netgear’s failure to make royalty payments, and provide corresponding
royalty reports to us based on sales of Netgear’s PoE products. On October 22, 2021, Netgear filed a Demand for Arbitration with
the American Arbitration Association (“AAA”) seeking to arbitrate certain issues raised in the litigation in the Supreme
Court, State of New York, County of New York. We have objected to jurisdiction at the AAA. On April 22, 2022, Netgear filed a counterclaim
in the New York court action alleging that we breached the License Agreement by not offering Netgear lower royalties. On September 22,
2022, the arbitration brought by Netgear was dismissed by the AAA on jurisdiction grounds. The case remains pending in the Supreme Court
of the State of New York, County of New York.
ITEM
4. MINE SAFETY DISCLOSURES
None.
PART
II
| ITEM 5. | MARKET
FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF
EQUITY SECURITIES |
Market
Information. Our common stock is listed for trading on the NYSE American exchange under the symbol “NTIP”. On March 23,
2023, the closing price for our common stock as reported on the NYSE American Exchange was $2.10 per share. The number of record holders
of our common stock was 39 as of March 23, 2023. In addition, we believe there were in excess of approximately 1200 holders of our common
stock in “street name” as of March 23, 2023.
Dividend
Policy. Our dividend policy consists of semi-annual cash dividends of $0.05 per share ($0.10 per share annually) which
have been paid in March and September of each year. On February 23, 2022, our Board of Directors declared a semi-annual
cash dividend of $0.05 per share with a payment date of March 24, 2022 to all common shareholders of record as of March 9, 2022. On September
9, 2022, our Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of September 30, 2022 to
all common shareholders of record as of September 20, 2022. On March 3, 2023, our Board of Directors declared a semi-annual cash
dividend of $0.05 per share with a payment date of March 31, 2023 to all common shareholders of record as of March 15, 2023. At this
time we anticipate continuing to pay dividends consistent with our policy. However, our dividend policy undergoes a periodic review by
our Board of Directors and is subject to change at any time depending upon our earnings, financial requirements and other factors existing
at the time.
As
of December 31, 2022, we accrued dividends of $37,000 for unvested restricted stock units with dividend equivalent rights.
Recent
Issuances of Unregistered Securities. There were no unregistered sales of equity securities during the quarter ended December 31,
2022.
Stock
Repurchases. On June 11, 2021, our Board of Directors authorized an extension and increase of the share repurchase program (“Share
Repurchase Program”) to repurchase up to $5,000,000 of shares of our common stock over the subsequent 24 month period. The common
stock may be repurchased from time to time in open market transactions or privately negotiated transactions in our discretion. The timing
and amount of the shares repurchased is determined by management based on its evaluation of market conditions and other factors. The
Share Repurchase Program may be increased, suspended or discontinued at any time.
During
the months of October, November and December 2022, we repurchased common stock pursuant to our Share Repurchase Program as indicated
below:
Period |
Total
Number of
Shares Purchased |
Average
Price
Paid Per Share |
Total
Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs |
Maximum
Number
(or Approximate
Dollar Value) of
Shares) that May
Yet Be Purchased
Under the Plans or
Programs |
October
1, 2022 to
October 31, 2022 |
— |
— |
— |
$3,508,374 |
November
1, 2022 to
November 30, 2022 |
4,210 |
$2.23 |
4,210 |
3,498,965 |
December
1, 2022 to
December 31, 2022 |
46,027 |
$2.20 |
46,027 |
3,397,891 |
Total |
50,237 |
$2.20 |
50,237 |
|
During
the year ended December 31, 2022, we repurchased an aggregate of 228,530 shares of our common stock pursuant to our Share Repurchase
Program at a cost of $531,000 (exclusive of commissions) or an average price per share of $2.33.
Since
inception of our Share Repurchase Program (August 2011) to December 31, 2022, we repurchased an aggregate of 9,212,664 shares of our
common stock at a cost of $17,758,000 (exclusive of commissions) or an average per share price of $1.93.
Equity
Compensation Plan Information
The
following table summarizes share and exercise price information for our equity compensation plans as of December 31, 2022.
|
|
Number
of
securities
to be
issued
upon
exercise
of
outstanding
options
and rights
|
|
Weighted-average
exercise
price of
outstanding
options
and
rights
|
|
Number
of securities remaining available for future issuance under equity compensation plans (excluding
securities reflected in column(a))
|
|
|
(a) |
|
(b) |
|
(c) |
|
|
|
|
|
|
|
Equity
compensation plans
approved by security holders |
|
625,000(1)
|
|
$
—(2) |
|
2,300,000(3)
|
|
|
|
|
|
|
|
Equity
compensation plans not
approved by security holders |
|
$ —
|
|
$ —
|
|
— |
|
|
|
|
|
|
|
Total |
|
625,000 |
|
$ — |
|
2,300,000 |
(1) Consists
of shares issuable upon vesting of outstanding restricted stock units issued under the 2013 Stock Incentive Plan.
(2) Does
not take into account outstanding restricted stock units as these awards have no exercise price.
(3) Represents
shares of common stock reserved for issuance under our 2022 Stock Incentive Plan. We have discontinued issuing awards under our 2013
Stock Incentive Plan as a result of adoption of the 2022 Stock Incentive Plan.
Our
2022 Stock Incentive Plan (“2022 Plan”) provides for the grant of any or all of the following types of awards: (a) stock
options, (b) restricted stock units (c) restricted stock, (d) stock appreciation rights, (e) unrestricted stock awards, (f) cash based
awards, and (g) other stock-based awards. Awards under the 2022 Plan may be granted singly, in combination, or in tandem. Subject
to standard anti-dilution adjustments as provided in the 2022 Plan, the 2022 Plan provides for an aggregate of 2,300,000 shares of our
common stock to be available for distribution pursuant to the 2022 Plan. The Compensation Committee (or the Board of Directors)
will generally have the authority to administer the 2022 Plan, determine participants who will be granted awards under the 2022 Plan,
the size and types of awards, the terms and conditions of awards and the form and content of the award agreements representing awards.
Awards under the 2022 Plan may be granted to our employees, directors and consultants. As of December 31, 2022, there were no awards
outstanding under our 2022 Plan and 625,000 shares issuable upon vesting restricted stock units under our 2013 Stock Incentive Plan (“2013
Plan”).
ITEM
6. (RESERVED)
Not
applicable.
ITEM
7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The
following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial
statements and related notes contained elsewhere in this Annual Report on Form 10-K. The following discussion contains forward-looking
statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking
statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Annual Report
on Form 10-K, particularly in the “Risk Factors” Section on pages 10-18 hereof.
OVERVIEW
Our
principal business is the development, licensing and protection of our intellectual property assets. We presently own ninety-seven (97)
U.S. patents and [eight] foreign patents relating to: (i) our Cox Patent Portfolio relating to enabling technology for
identifying media content on the Internet and taking further action to be performed after such identification; (ii) our M2M/IoT Patent
Portfolio relating to, among other things, enabling technology for authenticating, provisioning and using embedded Sim (Subscriber Identification
Module) technology in next generation IoT, Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers;
(iii) our HFT Patent Portfolio covering certain advanced technologies relating to high frequency trading, which inventions specifically
address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference
between success and failure may be measured in nanoseconds; (iv) our Mirror Worlds Patent Portfolio relating to foundational technologies
that enable unified search and indexing, displaying and archiving of documents in a computer system; and (v) our Remote Power Patent
covering the delivery of power over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless access
ports, IP phones and network based cameras. In addition, we continually review opportunities to acquire or license additional intellectual
property as well as other strategic alternatives.
At
December 31, 2022, our principal sources of liquidity consisted of cash and cash equivalents and marketable securities of $48,439,000
and working capital of $47,359,000. Based on our cash position, we continually review opportunities to acquire additional intellectual
property as well as evaluate other strategic opportunities.
To
date we have invested $7,000,000 in ILiAD, a clinical stage biotechnology company with an exclusive license to sixty-four patents. Although
in 2022 we recorded gains on our investment in ILiAD as referenced below, our investment continues to involve significant risk and the
outcome is uncertain.
We
had no revenue for the year ended December 31, 2022. During the year ended December 31, 2022, we recorded a gain on our equity investment
in ILiAD of $3,883,000 in accordance with ASC 323 due to an observable transaction price and dilution to our ownership of ILiAD as a
result of an ILiAD private offering as well as a gain on conversion of our convertible note from ILiAD of $271,000 in the private offering
(see Note B[6] and Note H to our consolidated financial statements included herein).
We
have been dependent upon our Remote Power Patent for a significant portion of our revenue. Our Remote Power Patent generated licensing
revenue in excess of $187,000,000 from May 2007 through December 31, 2022. We no longer receive licensing revenue for our Remote Power
Patent for any period subsequent March 7, 2020 (the expiration date of the patent). During the fourth quarter of 2022, we commenced separate
litigation against ten defendants involving our Remote Power Patent for patent infringement for the period prior to March 7, 2020 (see
“Legal Proceedings” on page 20 hereof).
In
addition, we have pending litigation involving certain patents within our Cox Patent Portfolio and have appealed the judgment of the
District Court dismissing our litigation against Meta (Facebook) on the grounds of non-infringement involving certain patents within
our Mirror Worlds Portfolio. We also intend to commence efforts to monetize certain patents within our M2M/IoT Patent Portfolio and HFT
Patent Portfolio. We may not achieve successful outcomes of such litigation, the appeal, or future litigation involving our patent assets.
Our
current strategy includes continuing our licensing efforts with respect to our intellectual property assets and the monetization of our
patent portfolios. In addition, we continue to seek to acquire additional intellectual property assets to develop, commercialize, license
or otherwise monetize. Our strategy includes working with inventors and patent owners to assist in the development and monetization of
their patented technologies. We may also enter into strategic relationships with third parties to develop, commercialize, license or
otherwise monetize their intellectual property. Our patent acquisition and development strategy is to focus on acquiring high quality
patents which management believes have the potential to generate significant licensing opportunities as we have achieved with respect
to our Remote Power Patent and Mirror Worlds Patent Portfolio.
On
March 25, 2022, we completed the acquisition of a new patent portfolio (the HFT Patent Portfolio) currently consisting of nine U.S. patents
and two pending U.S. patents (see Note I[2] to our consolidated financial statements included in this Annual Report).
The
significant components of expenses impacting our net income include income tax expense as a result of transactions with our equity method
investment in ILiAD. Other significant components of expenses impacting our net income when revenue is recorded relate to contingent
legal fees and expenses related to our patent litigation (see Note I[1] to our consolidated financial statements included herein) and
incentive compensation payable to our Chairman and Chief Executive Officer pursuant to his employment agreement (see Note J to our consolidated
financial statements included herein), both such components of expenses are based on a percentage of the licensing revenue received by
us as a result of litigation or otherwise.
Our
annual and quarterly operating and financial results may fluctuate significantly from period to period as a result of a variety of factors
that are outside our control, including the timing and our ability to achieve successful outcomes of our patent litigation, our ability
and timing of consummating future license agreements for our intellectual property, and whether we will achieve a return on our investment
in ILiAD and the timing of any such return.
Our
future operating results may also be materially impacted by our ability to acquire high quality patents which management believes have
the potential to generate significant licensing opportunities. In the future, we may not be able to identify or consummate such patent
acquisitions or, if consummated, achieve significant licensing revenue with respect to such acquisitions.
In
2023 and future years we could be classified as a Personal Holding Company. If this is the case, we would be subject to a 20% tax on
the amount of any undistributed personal holding company income (as defined) for such year that we do not distribute to our shareholders
(see Note E to our consolidated financial statements included in this Annual Report).
On
June 9, 2021, our Board of Directors approved the continuation of our dividend policy consisting of semi-annual cash dividends of $0.05
per share ($0.10 per share annually) which have been paid in March and September of each year. In 2022 and 2021, we paid semi-annual
cash dividends in accordance with our dividend policy. At this time we anticipate continuing to pay dividends consistent with our policy.
However, our dividend policy undergoes a periodic review by our Board of Directors and is subject to change at any time depending upon
our financial requirements, earnings and other factors existing at the time (see Note O to our consolidated financial statements included
herein).
RESULTS
OF OPERATIONS
Year
Ended December 31, 2022 Compared to Year Ended December 31, 2021
Revenue.
We had no revenue for the year ended December 31, 2022 (“2022”) as compared to revenue of $36,029,000 for the year ended
December 31, 2021 (“2021”). Revenue for 2021 resulted from our resolution of a contractual dispute with Cisco concerning
licensing of our Remote Power Patent and our litigation settlement with Hewlett-Packard.
Operating
Expenses. Operating expenses for 2022 were $3,903,000 as compared to $16,443,000 for 2021.
We
had costs of revenue of $-0- and $12,147,000 for 2022 and 2021, respectively. Included in the costs of revenue for 2021 were contingent
legal fees of $10,346,000 and incentive bonus compensation of $1,801,000 payable to our Chairman and Chief Executive Officer pursuant
to his employment agreement (see Note J[1] to our consolidated financial statements included herein).
Professional
fees and related costs were $809,000 for 2022 as compared to $1,500,000 for 2021 as a result of decreased expenses related to patent
litigation.
Stock-based
compensation was $585,000 for 2022 as compared to $238,000 for 2021. The increase in stock-based compensation expense was due to the
issuance of restricted stock units to our Chairman and Chief Executive Officer pursuant to his employment agreement (see Note J[1] to
our consolidated financial statements included herein).
Operating
(Loss) Income. We had an operating loss of $3,903,000 for 2022 compared with operating income of $19,586,000 for 2021. The operating
loss for 2022 was due to no revenue for the period as compared to revenue of $36,029,000 for 2021.
Interest
and Dividend Income. Interest and dividend income for 2022 was $1,020,000 as compared to $327,000 for 2021 primarily as a result
of a change in the mix of our short term fixed income investments and cash equivalents to higher yielding investments as interest rates
were rising in 2022.
Gain
on Conversion of Note. For 2022, we recorded a gain on conversion of our ILiAD convertible note of $271,000 as compared to $-0- for
2021 as a result of the conversion of the ILiAD convertible note and accrued interest into equity of ILiAD (see Note H to our consolidated
financial statements included herein).
Gain
on Equity Method Investment. For 2022, we recorded a gain on our equity method investment in ILiAD of $3,883,000 as compared to $-0-
for 2021, as a result of an unrealized gain in connection with ILiAD’s August 2022 private offering, which was accounted for as
an observable price transaction (see Note B[6] and Note H to our consolidated financial statements included herein).
Realized
and Unrealized Loss on Marketable Securities. For 2022, we recorded realized and unrealized losses on marketable securities of $1,351,000
as compared to $173,000 for 2021. The increased loss of $1,178,000 was due to unfavorable market conditions in the fixed income mutual
funds market in 2022 compared to 2021.
Income
Taxes. For 2022, we had $-0- current income tax for federal, state and local income taxes and a deferred tax expense of $607,000.
For 2021, we had a current tax expense for federal, state and local income taxes of $2,952,000 and a deferred tax expense of $1,508,000.
The net decrease of income tax expense of $3,853,000 was primarily due to no revenue in 2022.
Share
of Net Losses of Equity Method Investee. We incurred net losses of $1,639,000 and $999,000 during 2022 and 2021, respectively, related
to our equity method investment in ILiAD. The increase of $640,000 in the net losses of ILiAD includes an additional loss of $398,000
as a result of new information received from ILiAD in the fourth quarter of 2022 (see Note B[6] and Note H to our consolidated financial
statements included herein).
Net
(Loss) Income. As a result of the foregoing, we incurred a net loss of $2,326,000 or $0.10 per share basic and diluted for 2022 compared
with net income of $14,281,000 or $0.59 per share basic and $0.58 per share diluted for 2021. Our net loss for 2022 was due
to having no revenue and our continuing operating expenses supporting our patent portfolios, offset by our gain on equity method investment
of $3,883,000 and interest and dividend income of $1,020,000. In comparison, we had revenue of $36,029,000 for 2021 from the resolution
of our contractual dispute with Cisco and our litigation settlement with Hewlett-Packard.
LIQUIDITY
AND CAPITAL RESOURCES
We
have financed our operations primarily from revenue from licensing our patents. At December 31, 2022, our principal sources of liquidity
consisted of cash and cash equivalents and marketable securities of $48,439,000 and working capital of $47,359,000. Based on our current
cash position, we believe that we will have sufficient cash to fund our operations for the next twelve months and the foreseeable future.
Material increases in our liquidity and capital resources are primarily dependent upon litigation outcomes and licensing of our intellectual
property as well as whether we will be able to achieve returns on our investment in ILiAD.
Working
capital decreased by $8,306,000 at December 31, 2022 to $47,359,000 as compared to working capital of $55,665,000 at December 31,
2021. The decrease in working capital was primarily due to our operating loss of $3,903,000, payment of income taxes of $3,004,000,
cash dividends paid of $2,455,000, and an additional investment of $1,000,000 in ILiAD.
Net
cash (used in) provided by operating activities for 2022 decreased by $24,935,000 from $19,499,000 provided by operating activities for
2021 to $5,436,000 used in operating activities for 2022, primarily due to no revenue in 2022 as compared to revenue of $36,029,000 for
2021. In addition, in 2022 we paid $3,004,000 in income taxes related to 2021 taxable income.
Net
cash (used in) provided by investing activities during 2022 was $(22,271,000) as compared to $2,994,000 for 2021, primarily as a result
of the differential of increased purchases and decreased sales of marketable securities.
Net
cash used in financing activities for 2022 and 2021 was $3,342,000 and $3,501,000, respectively. The reduction of $159,000 primarily
resulted from repurchases of our common stock of $534,000 for 2022 compared to $1,077,000 of repurchases for 2021 and offset by an increase
of $341,000 in the value of shares delivered to fund withholding taxes for 2022.
We
maintain our cash in money market funds, government securities, certificates of deposit, and short-term fixed income securities. Accordingly,
we do not believe that our investments have significant exposure to interest rate risk.
OFF-BALANCE
SHEET ARRANGEMENTS
We
do not have any off-balance sheet arrangements.
CONTRACTUAL
OBLIGATIONS
We
do not have any long-term debt, capital lease obligations, purchase obligations or other long-term liabilities except for our lease obligations
for our principal office space (see Note I[4] to our consolidated financial statement included herein).
CRITICAL
ACCOUNTING POLICIES AND ESTIMATES
Our
discussion and analysis of our financial condition, results of operations and cash flows are based on our audited consolidated financial
statements which have been prepared in accordance with GAAP. The preparation of our financial statements included in this Annual Report
on Form 10-K requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during
the reporting periods. The significant estimates and assumptions made in the preparation of our consolidated financial statements include
revenue recognition, contingent legal fees and related expenses, income taxes, valuation of patents and equity method investments. Actual
results could be materially different from those estimates, upon which the carrying values were based. See also Note B to our consolidated
financial statements included in this Annual Report for full disclosure of our accounting policies.
We
believe our most critical accounting policies and estimates to be the following:
Equity
Method Investments
Equity
method investments are equity securities in entities that we do not control but over which we have the ability to exercise significant
influence. These investments are accounted for under the equity method of accounting in accordance with ASC 323, Investments —
Equity Method and Joint Ventures (see Note B[6] hereof). Equity method investments are measured at cost minus impairment,
if any, plus or minus our share of an investee’s income or loss, and adjustments based on the investees observable price transactions,
if any. Our proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag. When our carrying
value in an equity method investment is reduced to zero, no further losses are recorded in our financial statements unless we guaranteed
obligations of the investee company or have committed additional funding. When the investee company subsequently reports income, we will
not record our share of such income until it equals the amount of our share of losses not previously recognized. In the event the equity
method investee enters into an observable price transaction, the Company will increase or decrease the carrying value in its equity method
investment based on the transaction price. Upon sale of equity method investments, the difference between sales proceeds and the carrying
amount of the equity investment is recognized in profit or loss. In determining whether an equity method investment is impaired,
we take into consideration a variety of factors including the operating and financial performance of the investee, the investee’s
future business plans and projections, discussions with the investee’s management, and our intent and ability to hold the investment
until it recovers in value. Accordingly, we make assumptions and estimates in assessing whether an impairment has occurred and if, in
the future, our assumptions and estimates made in assessing the fair value of these investments change, this could result in a material
decrease in the carrying value of the investment. This would cause us to write-down the carrying value of the investment and could have
a material adverse effect on our results of operations in the period the impairment charge is taken.
Income
Taxes
We
account for income taxes in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic
740, Income Taxes (ASC 740), which requires us to use the assets and liability method of accounting for income taxes. Under the assets
and liability method, deferred income taxes are recognized for the tax consequences of temporary (timing) differences by applying enacted
statutory tax rates applicable to future years to differences between financial statement carrying amounts and the tax bases of existing
assets and liabilities and operating loss and tax credit carry forwards. Under this accounting standard, the effect on deferred income
taxes of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized
if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized. In evaluating the need for a valuation
allowance, we estimate future taxable income based on management business plans. This process involves significant management judgment
about assumptions that are subject to change from period to period. Because the recognition of deferred tax assets requires management
to make significant judgments about future earnings, the periods in which items will impact taxable income and the application of inherently
complex tax laws, we have identified the assessment of deferred tax assets and the need for any related valuation allowance as a critical
accounting estimate.
| ITEM
7A. | QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
Not
applicable.
| ITEM
8. | FINANCIAL
STATEMENTS AND SUPPLEMENTARY DATA |
The
consolidated financial statements required hereby are located on pages F-1 through F-23 which follow Part III.
| ITEM
9. | CHANGES
IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE |
None.
| ITEM
9A. | CONTROLS
AND PROCEDURES |
(a)
Evaluation of Disclosure Controls and Procedures
Our
Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of our disclosure controls and procedures (as defined
in Rule 13a-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered by this Annual Report on Form 10-K. Based
upon this review, our executive officers concluded that, as of the end of the period covered by this Annual Report on Form 10-K, our
disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports we file or
submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in
applicable rules and forms and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial
Officer, to allow timely decisions regarding required disclosure.
(b)
Internal Control Over Financial Reporting
(i) Management’s
Annual Report on Internal Control over Financial Reporting
Our
management is also responsible for establishing and maintaining adequate “internal control over financial reporting” of the
Company, as defined in Rule 13a-15(f) of the Exchange Act. Internal control over financial reporting is defined as a process
designed by, or under the supervision of, the issuer’s principal executive and principal financial officer and effected by the
board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting
and the
preparation
of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s
internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that,
in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable
assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted
accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management
and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition,
use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of
any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions,
or that the degree of compliance with the policies or procedures may deteriorate.
Management,
our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of our internal control over financial
reporting as of December 31, 2022 using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission
(COSO) in Internal Control - Integrated Framework (2013). Based upon that evaluation, our Chief Executive Officer and Chief
Financial Officer concluded that our internal controls over financial reporting were effective as of the end of the period covered by
this report.
(ii)
Attestation Report of Registered Public Accounting Firm
We
are a “smaller reporting company” as defined in Rule 12b-2 promulgated under the Securities Exchange Act of 1934, as amended,
and as such, are not required to provide the information contained in this sub-section pursuant to Item 308(b) of Regulation S-K. Accordingly,
this Annual Report on Form 10-K does not include an attestation report of our registered public accounting firm regarding internal control
over financial reporting.
(iii) Changes
in Internal Control over Financial Reporting
There
was no change in our internal control over financial reporting that occurred during the fiscal quarter ended December 31, 2022,
that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
| ITEM
9B. | OTHER
INFORMATION |
None.
| ITEM
9C. | DISCLOSURE
REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS |
Not
Applicable.
PART
III
ITEM 10. | | DIRECTORS,
EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE |
The
following information includes information each director and executive officer has given us about his or her age, all positions he or
she holds, his or her principal occupation and business experience for at least the past five years, and the names of other publicly-held
companies of which he or she currently serves as a director or has served as a director during the past five years. In addition to the
information presented regarding each director’s specific experience, qualifications, attributes and skills that led our Board to
the conclusion that he or she should serve as a director, we also believe that all of our directors have a reputation for integrity,
honesty and adherence to high ethical standards. They each have demonstrated business acumen, exercise sound judgment, and a commitment
of service to Network-1 and our Board.
Information
about the number of shares of our common stock beneficially owned by each executive officer and director appears in this Annual Report
under the heading “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” beginning
on page 43 hereof. There are no family relationships among any of our directors and executive officers.
NAME |
AGE |
POSITION |
Corey
M. Horowitz |
68 |
Chairman,
Chief Executive Officer and Chairman of the Board of Directors |
Jonathan
E. Greene |
61 |
Executive
Vice President, Secretary and a Director |
Robert
M. Mahan |
56 |
Chief
Financial Officer |
Emanuel
R. Pearlman |
63 |
Director |
Niv
Harizman |
58 |
Director |
Allison
Hoffman |
52 |
Director |
Corey
M. Horowitz has been our Chairman and Chief Executive Officer since December 2003. Mr. Horowitz has also served as Chairman of our
Board of Directors since January 1996 and has been a member of our Board of Directors since April 1994. In December 2018, Mr. Horowitz
became a member of the Board of Managers of ILiAD Biotechnologies, LLC, a privately held biotechnology company, in connection with our
investment in the company (see “Business-Investment in ILiAD Biotechnologies” at page 9 of this Annual Report). Mr. Horowitz
is also a member of the Life Sciences Institute Leadership Council at the University of Michigan. We believe Mr. Horowitz’s
qualifications to serve on our Board of Directors include his significant experience and expertise as an executive in the intellectual
property field, his understanding of our intellectual property and the patent acquisition, licensing and enforcement business combined
with his private equity and corporate transactional experience.
Jonathan
E. Greene became our Executive Vice President in October 2013 and our Secretary and a member of our Board of Directors in September
2022. He served as a consultant to the Company from December 2004 until March 2013, providing technical and marketing analysis for our
intellectual property portfolio. Mr. Greene became an employee of Network-1 in March 2013. From April 2006 to February 2009,
Mr. Greene served as a marketing consultant for Avatier Corporation, a developer of identity management software. From August 2003
until December 2004, he served as a consultant to Neartek, Inc., a storage management software company (August 2003 until October 2003)
and Kavado Inc., a security software company (November 2003 until December 2004). We believe Mr. Greene’s qualifications to serve
on our Board include his engineering and technical expertise to assist us in our patent acquisition, licensing and enforcement business.
Robert
M. Mahan became our Chief Financial Officer in December 2022. Mr. Mahan currently serves as President of Management and Financial
Services, Inc., a consulting firm that he founded in 2011 which provides general management, financial and operations consulting services
to private and public companies. From May 2021 to February 2022, Mr. Mahan served as Interim Chief Financial Officer of Loft Orbital
Solutions, Inc., a space infrastructure company that designs, launches and operates low earth orbit satellites. From April 2019 to May
2021, he served as the Interim Chief Financial Officer of XWELL, Inc., formerly XpresSpa Group, Inc., (NASDAQ: XWEL), a global health
and wellness holding company operating XpresCheck®, XpresSpa®, and Treat™ locations in airports. From November 2016 through
April 2019, Mr. Mahan served as the Chief Financial Officer of SkyBell Technologies, Inc., a company engaged in the video doorbell and
smart home industry. Mr. Mahan began his career in the audit practice of PricewaterhouseCoopers from 1989 through 1992 and as a Controller/Division
Chief Financial Officer of Tommy Hilfiger USA, Inc. from 1992 – 2001.
Emanuel
R. Pearlman has been a member of our Board of Directors since January 2012, where he serves as Chairman of our Audit Committee and
a member of our Nominating and Corporate Governance Committee. Mr. Pearlman currently serves as the Chairman and Chief Executive Officer
of Liberation Investment Group, a New York based investment management and financial consulting firm, which he founded in January 2003.
In March 2023, Mr. Pearlman became a member of the Board of Directors of QualTek
Services
Inc. (NASDAQ:QTEK, a leading turnkey provider of infrastructure services to North American 5G wireless, telecom, power grid modernization
and renewable energy sectors. Mr. Pearlman also serves as a member of the Special Committee of the Board to review and approve strategic
and financial alternatives. In March 2023, Mr. Pearlman also became a member of the Board of Directors of MidCap Financial Investment
Corporation (NASDAQ:MFIC), a closed-end externally managed, non-diversified management investment company that has elected to be treated
as a business development company. Mr. Pearlman also serves on the Audit, Nominating and Corporate Governance, and Compensation Committee
of MidCap Financial Investment Corp. In February 2023, Mr. Pearlman became a member of the Board of Directors of Diebold Nixdorf, Inc.
(NYSE: DBD), a multinational financial and retail technology company, and serves as a member of its Finance Committee and the People
and Compensation Committee. From March 2022 to April 2022, he was a member of the Board of Directors and Chair of the Strategic Review
Committee of Red Box Entertainment, Inc. (NASDAQ:RDBX), an entertainment company that provides consumers access to a large variety of
content across digital and physical media. From October 2020 to September 2021, Mr. Pearlman was a member of the Board of Directors of
Atlas Crest Investment Corp. (NYSE:ACIC) and during the period February 2021 until June 2022, he served on the Board of Directors of
Atlas Crest Investment Corp. II (NYSE:ACII), each entity is a special purpose acquisition company (SPAC). Mr. Pearlman served as Chairman
of the Audit Committee and a member of the Compensation Committee and Nomination & Governance Committee of Atlas Crest Investment
Corp. until September 2021 and held the same committee positions for Atlas Crest Investment Corp. II until June 2022. Mr. Pearlman served
as Executive Chairman of Empire Resorts, Inc. (NASDAQ:NYNY) from June 2016 until November 2019, served as Non-Executive Chairman of the
Board from September 2010 through May 2016, and served on the Board of Directors from May 2010 to November 2019. Mr. Pearlman was a member
of the Board of Directors of CEVA Logistics, AG (SIX:CEVA) from May 2018 until October 2019 and served on its Audit Committee from May
2018 through October 2019 and its Nomination and Governance Committee from May 2018 through May 2019. We believe Mr. Pearlman’s
qualifications to serve on our Board include his significant investment and financial experience and expertise combined with his Board
experience.
Niv
Harizman has been a member of our Board of Directors since December 2012. Mr. Harizman is a Managing Member of Tyto Capital Partners
LLC, a private investment firm specializing in debt and equity investments in middle market companies and special situations, a position
he has held since August 2010. Since March 2010, Mr. Harizman has also been the Managing Member of NHK Partners LLC, an entity that makes
private investments and provides consulting services. Since November 2013, Mr. Harizman has been affiliated with Riverside Management
Group, a merchant banking firm, and BCW Securities LLC, its affiliated broker-dealer. We believe Mr. Harizman’s qualifications
to serve on our Board include his significant investment and financial transactional experience and expertise.
Allison
Hoffman has been a member of our Board of Directors since December 2012. Since August 2020, Ms. Hoffman has served as General Counsel
of Phreesia, Inc. (NYSE:PHR), a leading provider of software solutions that healthcare organizations use to manage the patient intake
process. From January 2016 until August 2020, Ms. Hoffman served as Chief Legal Officer and Chief Administrative Officer at Intersection
Parent, Inc., an urban experience company that utilizes technology to make cities better, including bringing free Wi-Fi throughout New
York City. We believe that Ms. Hoffman’s qualifications to serve on our Board include her extensive legal background
and transactional experience.
Committees
of the Board of Directors
Our
Board of Directors currently has four standing committees: an Audit Committee; a Compensation Committee; a Nominating and Corporate Governance
Committee and a Strategic Development Committee. Each of the Audit Committee, Compensation Committee and Nominating and Corporate
Governance Committee has a charter. These charters are available on our website at: http://ir.Network-1.com/governance-docs.
Each member of each committee is an “independent” director under the standards of the NYSE American LLC Company Guide. Three
of our current five directors, Emanuel Pearlman, Allison Hoffman and Niv Harizman, are considered independent directors under Rule 803A(2)
of the NYSE American LLC Company Guide.
Audit
Committee
Our
Board of Directors has a separately standing audit committee in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of
1934, as amended, and Section 803B of the NYSE American Company LLC Guide consisting of Emanuel Pearlman (Chairman) and Allison Hoffman. Emanuel
Pearlman qualifies as an audit committee financial expert under applicable SEC rules. Mr. Pearlman and Ms. Hoffman qualify
as “independent” as independence for audit committee members is defined under Rule 10A-3 under the Securities Exchange Act
of 1934, as amended, and Section 803B(2) of the NYSE American LLC Company Guide.
The
Audit Committee is appointed by our Board of Directors to provide assistance to the Board in fulfilling its oversight responsibility
with respect to, among other things, (i) the integrity of our financial statements, (ii) our compliance with legal and regulatory requirements,
(iii) selecting and evaluating the qualifications and independence of our independent registered public accounting firm, (iv) evaluating
the performance of our internal audit function and independent registered public accounting firm, and (v) our internal controls and procedures.
Compensation
Committee
The
Compensation Committee consists of Allison Hoffman (Chair) and Niv Harizman. The Compensation Committee is appointed by our Board of
Directors to assist the Board in carrying out its responsibilities relating to compensation of our executive officers and directors. The
Committee has overall responsibility for evaluating and approving the officer and director compensation plans, policies and our programs.
Nominating
and Corporate Governance Committee
Our
Board has a Nominating and Corporate Governance Committee consisting of Niv Harizman (Chairman) and Emanuel Pearlman. The
Nominating and Corporate Governance Committee is responsible for, among other things, developing and recommending to the Board a set
of corporate governance policies for the Company, establishing criteria for selecting new directors, and identifying, screening and recruiting
new directors. The Committee also recommends to the Board nominees for directors and recommends directors for committee membership to
the Board.
Strategic
Development Committee
We
also have a Strategic Development Committee to assist our Chairman and Chief Executive Officer in strategic development and planning
of our business relating to identifying potential strategic partners, the acquisition of new IP and other acquisition opportunities. The
Committee also assists in capital markets related activities. Niv Harizman is the sole member of the Strategic Development Committee.
Code
of Ethics
We
have adopted a Code of Ethics that applies to our executive officers, directors and employees. Copies of the Code of Ethics may
be obtained, without charge, upon written request addressed to: Network-1 Technologies, Inc., 65 Locust Avenue, Third Floor, New Canaan,
Connecticut 06840, Attn: Chief Executive Officer.
ITEM
11. EXECUTIVE COMPENSATION
The
following table summarizes compensation for the years ended December 31, 2022 and December 31, 2021, awarded to, earned by or paid to
our Chief Executive Officer (“CEO”) and to each of our executive officers who received total compensation in excess of $100,000
for the year ended December 31, 2022 for services rendered in all capacities to us (collectively, the “Named Executive Officers”).
Summary
Compensation Table
Name
and Principal Position | |
Year | | |
Salary ($) | | |
Bonus ($) | | |
Stock
Awards($)(3) | | |
All
Other Compensation($)(1) | | |
Total($) | |
| |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
Corey M. Horowitz | |
2022 | | |
$ | 535,000 | | |
$ | 175,000 | (2) | |
$ | 1,102,940 | | |
$ | 109,675 | (4) | |
$ | 1,922,615 | |
Chairman and Chief Executive Officer | |
2021 | | |
$ | 535,000 | | |
$ | 1,976,000 | (2) | |
$ | — | | |
$ | 38,500 | (4) | |
$ | 2,549,500 | |
| |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
David C. Kahn | |
2022 | | |
$ | 175,000 | | |
$ | — | | |
$ | — | | |
$ | 17,282 | (5) | |
$ | 192,282 | |
Chief Financial Officer | |
2021 | | |
$ | 175,000 | | |
$ | 22,500 | | |
$ | — | | |
$ | 29,291 | (5) | |
$ | 226,791 | |
| |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
Jonathan Greene | |
2022 | | |
$ | 200,000 | | |
$ | 25,000 | | |
$ | 41,100 | (3) | |
$ | 20,419 | (6) | |
$ | 286,519 | |
Executive Vice President | |
2021 | | |
$ | 200,000 | | |
$ | 40,000 | | |
$ | — | | |
$ | 36,120 | (6) | |
$ | 276,120 | |
| ______________________________________________ | |
| (1) | We
have concluded that the aggregate amount of perquisites and other personal benefits paid
in 2022 and 2021 to either Mr. Horowitz, Mr. Kahn or Mr. Greene did not exceed $10,000. |
| (2) | Mr.
Horowitz received for 2022 an annual discretionary bonus of $175,000. Mr. Horowitz received
the following cash incentive bonus payments for 2021: (i) an annual discretionary bonus of
$175,000 and (ii) incentive bonus compensation of $1,801,000 pursuant to his employment agreement
(see “Employment Agreements – Termination of Employment Agreement and Change
in Control Arrangements” below). |
| (3) | The
amounts in this column represent the aggregate grant date fair value of restricted stock
units awards granted to the Named Executive Officers computed in accordance with FASB ASC
Topic 718. In accordance with SEC rules, the grant date fair value of an award that is subject
to a performance condition is based on the probable outcome of the performance condition.
See Note B[10] to our consolidated financial statements included in this Annual Report for
a discussion of the assumptions made by the Company in determining the grant date fair value. |
| (4) | Includes
401(k) matching funds contributions by the Company and profit sharing under the Company's
401(k) Plan for the benefit of Mr. Horowitz of $40,500 for 2022 and $38,500 for 2021, respectively.
Also includes dividends (dividend equivalent rights) on restricted stock units owned by Mr.
Horowitz for 2022 of $69,175 and 2021 of $-0-. |
| (5) | Includes
profit sharing under the Company's 401(k) Plan for the benefit of Mr. Kahn of $17,282 for
2022 and $28,728 for 2021. Also includes dividends (dividend equivalent rights)
on restricted stock units owned by Mr. Kahn for 2022 and 2021 of $-0- and $563, respectively.
Mr. Kahn retired as Chief Financial Officer of the Company on December 21, 2022. |
| (6) | Represents
profit sharing under the Company's 401(k) Plan for the benefit of Mr. Greene of $20,419 for
2022 and $35,201 for 2021. Also includes dividends (dividend equivalent rights)
on restricted stock units owned by Mr. Greene for 2022 and 2021 of $-0- and $919, respectively. |
Narrative
Disclosure to Summary Compensation Table
Employment
Agreements, Termination of Employment and Change-In-Control Arrangements
On
March 22, 2022, we entered into a new employment agreement (“Agreement”) with Corey M. Horowitz, our Chairman and Chief Executive
Officer, pursuant to which he continues to serve as our Chairman and Chief Executive Officer for a four year term (“Term”),
at an annual base salary of $535,000 which shall be increased by 3% per annum during the Term. The Agreement established an annual target
bonus of $175,000 for our Chairman and Chief Executive Officer based upon performance. For the year ended December 31, 2022 and 2021,
our Chairman and Chief Executive Officer received an annual discretionary bonus of $175,000.
In
addition, pursuant to the Agreement, we granted to our Chairman and Chief Executive Officer, under our 2013 Plan, 600,000 restricted
stock units (the “RSUs”, each RSU awarded by us to our officers, directors and consultants represents a contingent right
to receive one share of our common stock) which terms provided for vesting in four tranches, as follows: (1) 175,000 RSUs which
shall vest 100,000 RSUs on March 22, 2023 and 75,000 RSUs on March 22, 2024, subject to Mr. Horowitz’s continued employment by
us through each such vesting date (the “Employment Condition”) (“Tranche 1”); (2) 150,000 RSUs shall vest if
at any time during the Term our common stock achieves a closing price for twenty (20) consecutive trading days (“Closing Price”)
of a minimum of $3.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such
minimum per share Closing Price is achieved (“Tranche 2”); (3) 150,000 RSUs shall vest if at any time during the Term
our common stock achieves a Closing Price of a minimum of $4.00 per share (subject to adjustment for stock splits) and the Employment
Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 3”); and (4) 125,000
RSUs shall vest if at any time during the Term, our common stock achieves a Closing Price of a minimum of $4.50 per share (subject to
adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved
(“Tranche 4”). In the event of a Change of Control (as defined), Termination Other Than for Cause (as defined)
or a termination by Mr. Horowitz for Good Reason (as defined) in each case prior to the last day of the Term, the vesting of all RSUs
(Tranches 1, 2, 3 and 4) shall accelerate (and not be subject to any conditions) and all RSUs shall become immediately fully vested.
All RSUs granted by us to our officers, directors or consultants have dividend equivalent rights.
Under
the terms of the Agreement, so long as Mr. Horowitz continues to serve as an executive officer of the Company, whether pursuant to the
Agreement or otherwise, Mr. Horowitz shall also receive incentive compensation in an amount equal to 5% of our gross royalties or other
payments from Licensing Activities (as defined) (without deduction of legal fees or any other expenses) with respect to our Remote Power
Patent and a 10% net interest (gross royalties and other payments after deduction of all legal fees and litigation expenses related to
licensing, enforcement and sale activities, but in no event shall he receive less than 6.25% of the gross recovery) of our royalties
and other payments relating to Licensing Activities with respect to patents other than our Remote Power Patent (including all of our
existing patent portfolios and our investment in ILiAD) (collectively, the “Incentive Compensation”). During the year ended
December 31, 2022 and December 31, 2021, Mr. Horowitz earned Incentive Compensation of $-0- and $1,801,000, respectively.
The
Incentive Compensation shall continue to be paid to Mr. Horowitz for the life of each of our patents with respect to licenses entered
into with third parties during the Term or at any time thereafter, whether he is employed by us or not; provided, that, the employment
of Mr. Horowitz has not been terminated by us “For Cause” (as defined) or terminated by him without “Good Reason”
(as defined). In the event of a merger or sale of substantially all of our assets, we have the option to extinguish the right of Mr.
Horowitz to receive future Incentive Compensation by payment to him of a lump sum payment, in an amount equal to the fair market value
of such future interest as determined by an independent third party expert if the parties do not reach agreement as to such value. In
the event that Mr. Horowitz’s employment is terminated by us “Other Than For Cause” (as defined) or by him for “Good
Reason” (as defined), Mr. Horowitz shall also be entitled to (i) a lump sum severance payment of 12 months base salary, (ii) a
pro-rated portion of the $175,000 target bonus provided bonus criteria have been satisfied on a pro-rated basis through the calendar
quarter in which the termination occurs and (iii) accelerated vesting of all unvested options, RSUs or other awards.
In
connection with the Agreement, Mr. Horowitz has also agreed not to compete with us as follows: (i) during the Term and for a period of
12 months thereafter if his employment is terminated “Other Than For Cause” (as defined) provided he is paid his 12 month
base salary severance amount and (ii) for a period of two years from the termination date, if terminated “For Cause” by us
or “Without Good Reason” by Mr. Horowitz.
Jonathan
Greene serves as our Executive Vice President and Secretary on an at-will basis at an annual base salary of $200,000. Mr. Greene received
a discretionary annual bonus of $25,000 for 2022 and $40,000 in 2021. On December 29, 2020, Mr. Greene was granted 10,000 RSUs under
the 2013 Plan, 50% of such RSUs vested on the one year anniversary of the date of grant (December 29, 2021) and 50% of such RSUs vested
on the two year anniversary of the grant (December 29, 2022). On January 18, 2022, Mr. Greene was granted 15,000 RSUs under the 2022
Plan, 50% of such RSUs vested on the one year anniversary of the date of grant (January 18, 2023) and 50% of such RSUs vest on the
two year anniversary of the grant (January 18, 2024), subject to Mr. Greene’s continued employment.
David
Kahn served as our Chief Financial Officer on an at-will basis at an annual base salary of $175,000, until his retirement in December
2022. On December 29, 2020, Mr. Kahn was granted 7,500 RSUs under the 2013 Plan, 50% of such RSUs vested on the one year anniversary
of the grant (December 29, 2021) and 50% of such RSUs vested on the two year anniversary of the grant (December 29, 2022). In connection
with his retirement, Mr. Kahn was granted severance of six months base salary and certain other benefits.
Robert
Mahan serves as our Chief Financial Officer as of December 21, 2022 on a consulting basis at an annual compensation of $175,000.
Profit
Sharing 401(k) Plan
We
offer all employees who have completed a year of service (as defined) participation in a 401(k) retirement savings plan, which provides
a tax-advantaged method of saving for retirement. We expensed matching contributions and profit sharing of $78,000 and $102,000 under
the 401(k) plan for the years ended December 31, 2022 and 2021, respectively.
Director
Compensation
In
2022, we compensated each non-management director of our Company by granting to each such outside director 15,000 RSUs. The RSUs vested
in equal amounts of 3,750 RSUs on each of March 15, 2022, June 15, 2022, September 15, 2022 and December 15, 2022. In addition, we pay
our non-management directors cash director fees of $40,000 per annum ($10,000 per quarter). Non-management directors also receive additional
cash compensation on an annual basis for serving on the following Board committees: The Audit Committee Chairperson receives $7,500 and
members receive $5,000; the Chairperson and members of each of the Compensation Committee and Nominating and Corporate Governance Committee
receive annual fees of $3,750 and $2,500, respectively.
The
following table sets forth the compensation awarded to, earned by or paid to all persons who served as members of our Board of Directors
(other than our Named Executive Officers) during the year ended December 31, 2022. No director who is also a Named Executive Officer
received any compensation for services as a director in 2022.
Name |
|
Fees
earned or
paid in cash ($)(1) |
|
Stock
Awards
($)(2)
(3) |
|
All
other
compensation ($)(4) |
|
Total
($) |
Emanuel
Pearlman |
|
$50,000 |
|
$38,250 |
|
$1,125 |
|
$89,375 |
Niv
Harizman |
|
$46,250 |
|
$38,250 |
|
$ 725 |
|
$85,250 |
Allison
Hoffman |
|
$48,185 |
|
$38,250 |
|
$1,125 |
|
$87,560 |
___________________________
| (1) | Represents
directors’ fees payable in cash to each non-management director of $10,000 per quarter
($40,000 per annum) for 2022 plus additional cash fees for serving on Board committees as
disclosed above. |
| (2) | The
amounts included in this column represent the grant date fair value of restricted stock unit
awards (RSUs) granted to directors, computed in accordance with FASB ASC Topic 718. For a
discussion of valuation assumptions see Note B[10] to our consolidated financial statements
included in this Annual Report. The 15,000 RSUs granted to each non-management director vested
on a quarterly basis beginning March 15, 2022. Each restricted stock unit represents the
contingent right to receive one share of common stock. |
| (3) | As
of December 31, 2022, no stock options were owned by any of the above listed directors. |
| (4) | Includes
payment of dividends (dividend equivalent rights) on RSUs for 2022. |
Outstanding
Equity Awards at December 31, 2022
The
following table sets forth information relating to outstanding equity awards consisting of unvested restricted stock units for each Named
Executive Officer as of December 31, 2022 (there were no outstanding stock options):
|
Option
Awards |
Stock
Awards |
Name |
Number of Securities
Underlying Unexercised
Options |
Option
Exercise
Price ($) |
Option
Expiration
Date |
Equity
incentive plan awards: Number of unearned shares, units or other rights that have not vested |
Equity
incentive plan awards: Market value of unearned shares, units or other rights that have not
vested(1) ($) |
Exercisable
|
Unexercisable |
Corey
M. Horowitz
Chairman
and CEO
|
—
|
—
|
—
|
—
|
600,000(2) |
$1,320,000 |
Jonathan
Greene
Executive
Vice President |
—
|
— |
—
|
—
|
15,000(3) |
$33,000 |
________________________________
| (1) | In
accordance with SEC rules, market value is based on $2.20 per share representing the closing
price of our common stock on the last trading day of the year. |
| (2) | Represents
600,000 restricted stock units, the terms of the vesting of such restricted stock units are
disclosed on page 39 under “Employment Agreements - Termination of Employment and Change-In-Control
Arrangements.” |
| (3) | Represents
15,000 restricted stock units, which vested 7,500 restricted stock units on January 18, 2023
and will vest 7,500 restricted stock units on January 18, 2024, subject to Mr. Greene’s
continued employment. |
| ITEM
12. | SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS |
The
following table sets forth information regarding the beneficial ownership of our common stock as of March 10, 2023 for (i) each of our
directors, (ii) each of our executive officers, (iii) each person known by us to be the beneficial owner of more than 5% of our outstanding
shares of common stock, and (iv) all of our executive officers and directors as a group.
NAME AND ADDRESS OF BENEFICIAL OWNER |
|
AMOUNT AND NATURE OF BENEFICIAL OWNERSHIP (1)(2) |
|
|
PERCENTAGE OF COMMON STOCK BENEFICIALLY OWNED(2) |
|
Executive Officers and Directors: Corey M. Horowitz(3) |
|
|
6,782,292 |
|
|
|
28.4% |
|
CMH Capital Management Corp.(4) |
|
|
2,291,372 |
|
|
|
9.6% |
|
Niv Harizman(5) |
|
|
290,985 |
|
|
|
1.2% |
|
Emanuel Pearlman(6) |
|
|
117,059 |
|
|
|
* |
|
Jonathan E. Greene(7) |
|
|
93,945 |
|
|
|
* |
|
Allison Hoffman(8) |
|
|
79,311 |
|
|
|
* |
|
Robert Mahan |
|
|
— |
|
|
|
— |
|
All officers and directors as a group (6 Persons) |
|
|
7,363,592 |
|
|
|
30.8% |
|
5% Stockholders: |
|
|
|
|
|
|
|
|
Steven D. Heinemann(9) |
|
|
2,052,769 |
|
|
|
8.6% |
|
Goose Hill Capital LLC(10) |
|
|
1,467,636 |
|
|
|
6.2% |
|
_____________________________________
* Less
than 1%.
| (1) | Unless
otherwise indicated, we believe that all persons named in the above table have sole voting
and investment power with respect to all shares of our common stock beneficially owned by
them. Unless otherwise indicated the address for each listed beneficial owner is c/o Network-1
Technologies, Inc., 65 Locust Avenue, Third Floor, New Canaan, Connecticut 06840. |
| (2) | A
person is deemed to be the beneficial owner of shares of common stock that can be acquired
by such person within 60 days from March 10, 2023 upon the exercise of stock options or restricted
stock units that vest within such 60 day period. Each beneficial owner's percentage ownership
is determined by assuming that all stock options and restricted stock units held by such
person (but not those held by any other person) and which are exercisable or vest within
60 days from March 10, 2023 have been exercised or vested. Assumes a base
of 23,790,005 shares of our common stock outstanding as of March 10, 2023. |
| (3) | Includes
(i) 3,868,909 shares of common stock owned by Mr. Horowitz, (ii) 100,000 shares of common
stock subject to restricted stock units that vest within 60 days of March 10, 2023 (iii) 2,157,097
shares of common stock held by CMH Capital Management Corp., an entity solely owned by Mr.
Horowitz, (iv) 134,275 shares of common stock owned by the CMH Capital Management Corp. Profit
Sharing Plan, of which Mr. Horowitz is the trustee, (v) 67,470 shares of common stock
owned by Donna Slavitt, the wife of Mr. Horowitz, (vi) an aggregate of 452,250 shares of
common stock held by two trusts and a custodian account for the benefit of Mr. Horowitz’s
three children, and (vii) 2,291 shares of common stock held by Horowitz Partners, a general
partnership of which Mr. Horowitz is a partner. Does not include 500,000 restricted stock
units owned by Mr. Horowitz that do not vest within 60 days of March 10, 2023. |
| (4) | Includes
2,157,097 shares of common stock owned by CMH Capital Management Corp. and 134,275 shares
of common stock owned by CMH Capital Management Corp. Profit Sharing Plan. Corey
M. Horowitz, by virtue of being the sole officer, director and shareholder of CMH Capital
Management Corp. and the trustee of the CMH Capital Management Corp. Profit Sharing Plan,
has the sole power to vote and dispose of the shares of common stock owned by CMH Capital
Management Corp. and the CMH Capital Management Corp. Profit Sharing Plan. |
| (5) | Includes
(i) 287,235 shares of common stock and (ii) 3,750 shares of common stock subject to restricted
stock units that vest within 60 days of March 10, 2023. Does not include 11,250 shares of
common stock subject to restricted stock units owned by Mr. Harizman that do not vest within
60 days from March 10, 2023. |
| (6) | Includes
(i) 113,309 shares of common stock and (ii) 3,750 shares of common stock subject to restricted
stock units that vest within 60 days of March 10, 2023. Does not include 11,250 shares of
common stock subject to restricted stock units owned by Mr. Pearlman that do not vest within
60 days from March 10, 2023. |
| (7) | Includes
93,945 shares of common stock. Does not include 22,500 shares of common stock
subject to restricted stock units owned by Mr. Greene that do not vest within 60 days from
March 10, 2023. |
| (8) | Includes
(i) 75,561 shares of common stock and (ii) 3,750 shares of common stock subject to restricted
stock units that vest within 60 days of March 10, 2023. Does not include 11,250 shares of
common stock subject to restricted stock units owned by Ms. Hoffman that do not vest within
60 days from March 10, 2023. |
| (9) | Includes
585,133 shares of common stock owned by Mr. Heinemann and 1,467,636 shares of common
stock owned by Goose Hill Capital LLC. Goose Hill Capital LLC is a limited liability company
of which Mr. Heinemann is the sole member. Mr. Heinemann, by virtue of being the sole
member of Goose Hill Capital LLC, has the sole power to vote and dispose of the shares of
common stock owned by Goose Hill Capital LLC. The aforementioned beneficial ownership is
based upon Amendment No. 10 to Schedule 13G filed by Mr. Heinemann with the SEC on February
14, 2023. The address for Mr. Heinemann is c/o Goose Hill Capital, LLC, 12378
Indian Road, North Palm Beach, Florida 33408. |
| (10) | Includes
1,467,636 shares of common stock. Steven D. Heinemann, by virtue of being the sole member
of Goose Hill Capital LLC, has the sole power to vote and dispose of the shares of common
stock owned by Goose Hill Capital LLC. The aforementioned beneficial ownership is based upon
Amendment No. 10 to Schedule 13G filed by Mr. Heinemann with the SEC on February 14,
2023. The address for Goose Hill Capital LLC is 12378 Indian Road, North Palm Beach, Florida
33408. |
| ITEM
13. | CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE |
On
June 1, 2022, we repurchased from Allison Hoffman, a director of the Company, 41,500 shares of its common stock at a purchase price of
$2.42 per share for an aggregate purchase price of $100,430.
Review,
Approval or Ratification of Transactions with Related Persons
The
Audit Committee has responsibility for reviewing and approving related-persons transactions in accordance with its charter. A related
person is any executive officer, director, nominee for director or more than 5% stockholder of the Company, including immediate family
members, and any entity owned or controlled by such persons. In addition, pursuant to our Code of Ethics, all of our officers, directors
and employees are to avoid conflicts of interest and to refrain from taking part or exercising influence in any transaction in which
such party’s personal interest may conflict with the best interest of the Company. Except for provisions of the Audit
Committee Charter, there are no written procedures governing review of related-persons transactions.
Director
Independence
Three
of our five directors, Emanuel Pearlman, Niv Harizman and Allison Hoffman, are considered independent directors in compliance with the
standard of independence in Section 803A(2) of the NYSE American LLC Company Guide.
| ITEM
14. | PRINCIPAL
ACCOUNTANT FEES AND SERVICES |
Audit
Fees
Marcum
LLP, our independent registered public accounting firm as of October 11, 2022, billed us aggregate fees of $103,200 for the year ended
December 31, 2022, for the audit of our annual financial statements, review of our financial statements included in our Form 10-Q
for the three months ended September 30, 2022 and for other services in connection with statutory or regulatory filings. Friedman LLP,
our independent registered public accounting firm until October 11, 2022, billed us aggregate fees of $48,832 and $135,535 for the years
ended December 31, 2022 and 2021, respectively, for the audit of our financial statements for 2021, review of our financial statements
included in our Form 10-Qs and for other services in connection with statutory and regulatory filings.
Tax
Fees and Other Fees
Marcum
LLP provided various tax and compliance services for which it billed us $30,320 for the year ended December 31, 2022. Friedman LLP provided
various tax and compliance services for which it billed us $3,271 and $22,890, respectively, for the years ended December 31, 2022 and
December 31, 2021 which included preparation of our tax returns. Marcum LLP and Friedman LLP did not render any other professional services
other than those discussed above for 2022.
Audit
Committee Pre-Approval Policies and Procedures
Our
audit committee charter provides that our audit committee must comply with SEC rules to maintain auditor independence as set forth in
Rule 2-01(c)(7)(i) of Regulation S-X. The Audit Committee has a policy to pre-approve all audit and permissible non-audit services to
be provided by our independent registered public accounting firm. All the services above were approved in advance by our Board of Directors.
NETWORK-1
TECHNOLOGIES, INC.
|
|
Index
to Consolidated Financial Statements
|
Page |
|
|
Reports of Independent
Registered Public Accounting Firms (PCAOB Firm ID 688 and 711) |
F-1 |
|
|
Consolidated
Balance Sheets as of December 31, 2022 and 2021 |
F-3 |
|
|
Consolidated
Statements of Operations and Comprehensive Income (Loss) for the years ended December 31, 2022 and 2021 |
F-4 |
|
|
Consolidated
Statements of Changes in Stockholders' Equity for the years ended December 31, 2022 and 2021 |
F-5 |
|
|
Consolidated
Statements of Cash Flows for the years ended December 31, 2022 and 2021 |
F-6 |
|
|
Notes
to Consolidated Financial Statements |
F-7 |
|
|
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To
the Shareholders and Board of Directors of
Network-1
Technologies, Inc
Opinion
on the Financial Statements
We
have audited the accompanying consolidated balance sheet of Network-1 Technologies, Inc. (the “Company”) as of December 31,
2022, the related consolidated statements of operations and comprehensive (loss), changes in stockholders’ equity, and cash flows
for the year ended December 31, 2022, and the related notes (collectively referred to as the “financial statements”).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company
as of December 31, 2022, and the results of its operations and its cash flows for the year ended December 31, 2022 in conformity with
accounting principles generally accepted in the United States of America.
Basis
for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on
the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.
We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing
an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.
Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due
to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that our audit provides a reasonable basis for our opinion.
Critical
Audit Matters
Critical
audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be
communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and
(2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.
/s/
Marcum llp
Marcum LLP
We
have served as the Company’s auditor since 2014 (such date takes into account the acquisition of certain assets of Friedman LLP
by Marcum LLP effective September 1, 2022)
New
York, New York
March 30, 2023
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To
the Board of Directors and Stockholders
Network-1
Technologies, Inc.
Opinion
on the Financial Statements
We
have audited the accompanying consolidated balance sheet of Network-1 Technologies, Inc. and Subsidiary (the “Company”)
as of December 31, 2021, and the related consolidated statements of operations and comprehensive income, changes in stockholders’
equity and cash flows for the year ended December 31, 2021, and the related notes (collectively referred to as the “financial statements”).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2021, and the results of its operations and its cash flows for the year ended December 31, 2021, in conformity with accounting
principles generally accepted in the United States of America.
Basis
for Opinion
These
financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.
Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides
a reasonable basis for our opinion.
/s/
Friedman LLP
We
have served as the Company’s auditor from 2014 to 2022.
New
York, New York
March 30, 2022
NETWORK-1
TECHNOLOGIES, INC.
CONSOLIDATED
BALANCE SHEETS
| |
| | | |
| | |
| |
December
31, | |
| |
2022 | | |
2021 | |
ASSETS: | |
| | |
| |
| |
| | | |
| | |
CURRENT ASSETS: | |
| | | |
| | |
Cash and cash equivalents | |
$ | 13,448,000 | | |
$ | 44,497,000 | |
Marketable securities, at fair value | |
| 34,991,000 | | |
| 15,126,000 | |
Prepaid taxes | |
| 177,000 | | |
| — | |
Other current assets | |
| 348,000 | | |
| 150,000 | |
| |
| | | |
| | |
Total Current Assets | |
| 48,964,000 | | |
| 59,773,000 | |
| |
| | | |
| | |
OTHER ASSETS: | |
| | | |
| | |
Patents, net of accumulated amortization | |
| 1,592,000 | | |
| 1,384,000 | |
Equity investment | |
| 7,252,000 | | |
| 2,651,000 | |
Convertible note investment | |
| — | | |
| 1,000,000 | |
Operating leases right of use asset | |
| 161,000 | | |
| — | |
Security deposits | |
| — | | |
| 13,000 | |
| |
| | | |
| | |
Total Other Assets | |
| 9,005,000 | | |
| 5,048,000 | |
| |
| | | |
| | |
TOTAL ASSETS | |
$ | 57,969,000 | | |
$ | 64,821,000 | |
| |
| | | |
| | |
LIABILITIES AND STOCKHOLDERS’ EQUITY: | |
| | | |
| | |
| |
| | | |
| | |
CURRENT LIABILITIES: | |
| | | |
| | |
Accounts payable | |
$ | 507,000 | | |
$ | 459,000 | |
Income taxes payable | |
| 115,000 | | |
| 2,952,000 | |
Accrued contingency fees and related costs | |
| — | | |
| 137,000 | |
Accrued payroll | |
| 317,000 | | |
| 380,000 | |
Other accrued expenses | |
| 587,000 | | |
| 180,000 | |
Operating lease obligations, current | |
| 79,000 | | |
| — | |
| |
| | | |
| | |
Total Current Liabilities | |
| 1,605,000 | | |
| 4,108,000 | |
| |
| | | |
| | |
LONG TERM LIABILITIES: | |
| | | |
| | |
Deferred tax liability | |
| 1,161,000 | | |
| 554,000 | |
Operating lease obligation, non-current | |
| 94,000 | | |
| — | |
| |
| | | |
| | |
TOTAL LIABILITIES | |
$ | 2,860,000 | | |
$ | 4,662,000 | |
| |
| | | |
| | |
COMMITMENTS AND CONTINGENCIES (See Note I) | |
| | | |
| | |
| |
| | | |
| | |
STOCKHOLDERS' EQUITY | |
| | | |
| | |
| |
| | | |
| | |
Preferred
stock, $0.01 par value; authorized 10,000,000 shares; none
issued and outstanding at December 31, 2022 and December 31, 2021 | |
| — | | |
| — | |
Common
stock, $0.01 par value; authorized 50,000,000 shares; 23,863,639
and 23,792,212 shares issued and outstanding at December 31, 2022 and December 31, 2021,
respectively | |
| 239,000 | | |
| 238,000 | |
| |
| | | |
| | |
Additional paid-in capital | |
| 66,939,000 | | |
| 66,361,000 | |
Accumulated deficit | |
| (12,055,000 | ) | |
| (6,428,000 | ) |
Accumulated other comprehensive
loss | |
| (14,000 | ) | |
| (12,000 | ) |
| |
| | | |
| | |
TOTAL STOCKHOLDERS’
EQUITY | |
| 55,109,000 | | |
| 60,159,000 | |
TOTAL
LIABILITIES AND STOCKHOLDERS’ EQUITY | |
$ | 57,969,000 | | |
$ | 64,821,000 | |
The
accompanying notes are an integral part of the consolidated financial statements
NETWORK-1
TECHNOLOGIES, INC.
CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
| |
| | | |
| | |
| |
Years
Ended December 31, | |
| |
2022 | | |
2021 | |
REVENUE | |
$ | — | | |
$ | 36,029,000 | |
| |
| | | |
| | |
OPERATING EXPENSES: | |
| | | |
| | |
Costs of revenue | |
| — | | |
| 12,147,000 | |
Professional fees and related costs | |
| 809,000 | | |
| 1,500,000 | |
General and administrative | |
| 2,778,000 | | |
| 2,501,000 | |
Amortization of patents | |
| 316,000 | | |
| 295,000 | |
| |
| | | |
| | |
TOTAL OPERATING
EXPENSES | |
| 3,903,000 | | |
| 16,443,000 | |
| |
| | | |
| | |
OPERATING INCOME (LOSS) | |
| (3,903,000 | ) | |
| 19,586,000 | |
OTHER
INCOME | |
| | | |
| | |
Interest and dividend income, net | |
| 1,020,000 | | |
| 327,000 | |
Gain on conversion of note | |
| 271,000 | | |
| — | |
Gain on equity method investment | |
| 3,883,000 | | |
| — | |
Net realized and unrealized loss
on marketable securities | |
| (1,351,000 | ) | |
| (173,000 | ) |
Total other income, net | |
| 3,823,000 | | |
| 154,000 | |
| |
| | | |
| | |
| |
| | | |
| | |
INCOME TAXES PROVISION: | |
| | | |
| | |
Current | |
| — | | |
| 2,952,000 | |
Deferred taxes, net | |
| 607,000 | | |
| 1,508,000 | |
Total income taxes expense | |
| 607,000 | | |
| 4,460,000 | |
| |
| | | |
| | |
(LOSS)
INCOME BEFORE SHARE OF NET LOSSES OF EQUITY
METHOD INVESTEE: | |
| (687,000 | ) | |
| 15,280,000 | |
| |
| | | |
| | |
SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE | |
| (1,639,000 | ) | |
| (999,000 | ) |
| |
| | | |
| | |
NET (LOSS) INCOME | |
$ | (2,326,000 | ) | |
$ | 14,281,000 | |
| |
| | | |
| | |
Net (Loss) Income Per Share: | |
| | | |
| | |
Basic | |
$ | (0.10 | ) | |
$ | 0.59 | |
Diluted | |
$ | (0.10 | ) | |
$ | 0.58 | |
| |
| | | |
| | |
Weighted average common shares outstanding: | |
| | | |
| | |
Basic | |
| 23,825,917 | | |
| 24,136,821 | |
Diluted | |
| 23,825,917 | | |
| 24,530,568 | |
| |
| | | |
| | |
Cash dividends declared per share | |
$ | 0.10 | | |
$ | 0.10 | |
| |
| | | |
| | |
NET (LOSS) INCOME | |
$ | (2,326,000 | ) | |
$ | 14,281,000 | |
| |
| | | |
| | |
OTHER COMPREHENSIVE LOSS | |
| | | |
| | |
Net unrealized holding loss on
corporate bonds and notes arising during the year, net of tax | |
| (2,000 | ) | |
| (2,000 | ) |
| |
| | | |
| | |
COMPREHENSIVE (LOSS) INCOME | |
$ | (2,328,000 | ) | |
$ | 14,279,000 | |
The
accompanying notes are an integral part of the consolidated financial statements
NETWORK-1
TECHNOLOGIES, INC.
CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
Common Stock | | |
| | |
| | |
| | |
Total
Stockholders’ Equity | |
| |
Shares | | |
Amount | | |
Additional Paid-in Capital | | |
Accumulated
Deficit | | |
Accumulated Other Comprehensive (Loss) | | |
Total
Stockholders’
Equity | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance – January 1, 2021 | |
| 24,105,879 | | |
$ | 241,000 | | |
$ | 66,124,000 | | |
$ | (17,193,000 | ) | |
$ | (10,000 | ) | |
$ | 49,162,000 | |
Dividends and dividend equivalents declared | |
| — | | |
| — | | |
| — | | |
| (2,429,000 | ) | |
| — | | |
| (2,429,000 | ) |
Stock-based compensation | |
| — | | |
| — | | |
| 238,000 | | |
| — | | |
| — | | |
| 238,000 | |
Vesting of restricted stock units | |
| 70,000 | | |
| 1,000 | | |
| (1,000 | ) | |
| — | | |
| — | | |
| — | |
Value of shares delivered to pay withholding taxes | |
| (5,192 | ) | |
| — | | |
| — | | |
| (14,000 | ) | |
| — | | |
| (14,000 | ) |
Treasury stock purchased and retired | |
| (378,475 | ) | |
| (4,000 | ) | |
| — | | |
| (1,073,000 | ) | |
| — | | |
| (1,077,000 | ) |
Net unrealized loss on corporate bonds and notes | |
| — | | |
| — | | |
| — | | |
| — | | |
| (2,000 | ) | |
| (2,000 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| 14,281,000 | | |
| — | | |
| 14,281,000 | |
Balance – December 31, 2021 | |
| 23,792,212 | | |
$ | 238,000 | | |
$ | 66,361,000 | | |
$ | (6,428,000 | ) | |
$ | (12,000 | ) | |
$ | 60,159,000 | |
Dividends and dividend equivalents declared | |
| — | | |
| — | | |
| — | | |
| (2,418,000 | ) | |
| — | | |
| (2,418,000 | ) |
Stock-based compensation | |
| — | | |
| — | | |
| 585,000 | | |
| — | | |
| — | | |
| 585,000 | |
Vesting of restricted stock units | |
| 182,500 | | |
| 2,000 | | |
| (2,000 | ) | |
| — | | |
| — | | |
| — | |
Cashless exercise of stock options | |
| 500,000 | | |
| 5,000 | | |
| (5,000 | ) | |
| — | | |
| — | | |
| — | |
Value of shares delivered to pay exercise price and withholding taxes | |
| (382,543 | ) | |
| (3,000 | ) | |
| — | | |
| (352,000 | ) | |
| — | | |
| (355,000 | ) |
Treasury stock purchased and retired | |
| (228,530 | ) | |
| (3,000 | ) | |
| — | | |
| (531,000 | ) | |
| — | | |
| (534,000 | ) |
Net unrealized loss on corporate bonds and notes | |
| — | | |
| — | | |
| — | | |
| — | | |
| (2,000 | ) | |
| (2,000 | ) |
Net loss | |
| — | | |
| — | | |
| — | | |
| (2,326,000 | ) | |
| — | | |
| (2,326,000 | ) |
Balance – December 31, 2022 | |
| 23,863,639 | | |
$ | 239,000 | | |
$ | 66,939,000 | | |
$ | (12,055,000 | ) | |
$ | (14,000 | ) | |
$ | 55,109,000 | |
The
accompanying notes are an integral part of the consolidated financial statements
NETWORK-1
TECHNOLOGIES, INC.
CONSOLIDATED
STATEMENTS OF CASH FLOWS
| |
| | | |
| | |
| |
Years
Ended December 31,
| |
| |
2022 | | |
2021 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | |
| | | |
| | |
Net (loss) income | |
$ | (2,326,000 | ) | |
$ | 14,281,000 | |
Adjustments
to reconcile net (loss) income to net cash
used in operating activities: | |
| | | |
| | |
Amortization of patents | |
| 316,000 | | |
| 295,000 | |
Stock-based compensation | |
| 585,000 | | |
| 238,000 | |
Loss allocated from equity investment | |
| 1,639,000 | | |
| 999,000 | |
Deferred tax expense | |
| 607,000 | | |
| 1,508,000 | |
Amortization of right of use asset, net | |
| 43,000 | | |
| — | |
Gain on equity method investment | |
| (3,883,000 | ) | |
| — | |
Accrued interest on convertible note | |
| (86,000 | ) | |
| — | |
Gain on conversion of note | |
| (271,000 | ) | |
| — | |
Unrealized loss on marketable securities | |
| 880,000 | | |
| 148,000 | |
Changes in operating assets and
liabilities: | |
| | | |
| | |
Other current assets | |
| (208,000 | ) | |
| (30,000 | ) |
Prepaid taxes | |
| (167,000 | ) | |
| — | |
Accounts payable | |
| 48,000 | | |
| (142,000 | ) |
Income taxes payable | |
| (2,837,000 | ) | |
| 2,952,000 | |
Security deposit | |
| 13,000 | | |
| 8,000 | |
Operating lease obligations | |
| (31,000 | ) | |
| — | |
Accrued expenses | |
| 242,000 | | |
| (758,000 | ) |
| |
| | | |
| | |
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES | |
| (5,436,000 | ) | |
| 19,499,000 | |
| |
| | | |
| | |
CASH FLOWS FROM INVESTING ACTIVITIES: | |
| | | |
| | |
Sales of marketable securities | |
| 13,156,000 | | |
| 17,154,000 | |
Development of patents | |
| (524,000 | ) | |
| (101,000 | ) |
Equity Investment | |
| (1,000,000 | ) | |
| — | |
Convertible note investment | |
| — | | |
| (1,000,000 | ) |
| |
| | | |
| | |
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES | |
| (22,271,000 | ) | |
| 2,994,000 | |
| |
| | | |
| | |
CASH FLOWS FROM FINANCING ACTIVITIES: | |
| | | |
| | |
Cash dividends paid | |
| (2,453,000 | ) | |
| (2,410,000 | ) |
Value of shares delivered to fund withholding taxes | |
| (355,000 | ) | |
| (14,000 | ) |
Repurchases of common stock, inclusive
of commissions | |
| (534,000 | ) | |
| (1,077,000 | ) |
| |
| | | |
| | |
NET CASH USED IN FINANCING ACTIVITIES | |
| (3,342,000 | ) | |
| (3,501,000 | ) |
| |
| | | |
| | |
NET (DECREASE) INCREASE IN CASH AND
CASH EQUIVALENTS | |
| (31,049,000 | ) | |
| 18,992,000 | |
| |
| | | |
| | |
CASH AND CASH EQUIVALENTS, beginning of year | |
| 44,497,000 | | |
| 25,505,000 | |
| |
| | | |
| | |
CASH AND CASH EQUIVALENTS, end of
year | |
$ | 13,448,000 | | |
$ | 44,497,000 | |
| |
| | | |
| | |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | |
| | | |
| | |
Cash paid during the years for: | |
| | | |
| | |
Interest | |
$ | — | | |
$ | — | |
Income taxes | |
$ | 3,004,000 | | |
$ | — | |
| |
| | | |
| | |
NON-CASH FINANCING ACTIVITY | |
| | | |
| | |
Accrued dividend rights on restricted
stock units | |
$ | 37,000 | | |
$ | 20,000 | |
Right of use asset obtained in
exchange for lease liability | |
$ | 204,000 | | |
| — | |
Conversion of note receivable | |
$ | 1,086,000 | | |
| — | |
The
accompanying notes are an integral part of the consolidated financial statements
NETWORK-1
TECHNOLOGIES, INC.
Note
A – Business
Network-1
Technologies, Inc. (the “Company”) is engaged in the development, licensing and protection of its intellectual property
assets. The Company presently owns ninety-seven (97)
U.S. patents, fifty-two (52) of such patents have expired, and eight (8)
foreign patents related to (i) the Cox patent portfolio (the “Cox Patent Portfolio) relating to enabling technology for
identifying media content on the Internet and taking further actions to be performed after such identification; (ii) the M2M/IoT
patent portfolio (the “M2M/IoT Patent Portfolio”) relating to, among other things, enabling technology for
authenticating, provisioning and using embedded SIM (Subscriber Identification Module)technology in next generation IoT,
Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers; (iii) the HFT patent portfolio (the
“HFT Patent Portfolio”) covering certain advanced technologies relating to high frequency trading, which inventions
specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems
where the difference between success and failure may be measured in nanoseconds; (iv) the Mirror Worlds patent portfolio (the
“Mirror Worlds Patent Portfolio”) relating to foundational technologies that enable unified search and indexing,
displaying and archiving of documents in a computer system; and (v) the remote power patent (the “Remote Power Patent”)
covering delivery of Power over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless access
ports, IP phones and network based cameras.
The
Company’s current strategy includes continuing to pursue licensing opportunities for its intellectual property assets. In addition,
the Company continually reviews opportunities to acquire or license additional intellectual property as well as other strategic alternatives.
The Company’s patent acquisition and development strategy is to focus on acquiring high quality patents which management believes
have the potential to generate significant licensing opportunities as the Company has achieved with respect to its Remote Power Patent
and Mirror Worlds Patent Portfolio. In addition, the Company may also enter into strategic relationships with third parties to develop,
commercialize, license or otherwise monetize their intellectual property.
The
Company has made equity investments totaling $7,000,000 in ILiAD Biotechnologies, LLC (“ILiAD”), a clinical stage biotechnology
company (see Note H hereof).
Note
B – Summary
of Significant Accounting Policies
| [1] | Principles
of Consolidation |
The
Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (“U.S. GAAP”). The accompanying financial statements include the accounts of the Company and its
wholly-owned subsidiaries, Mirror Worlds Technologies, LLC and HFT Solutions, LLC. All intercompany transactions and balances are eliminated
in consolidation.
| [2] | Use
of Estimates and Assumptions |
The
preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated
financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions
made in the preparation of the Company’s consolidated financial statements primarily include costs related to the Company’s
assertion of litigation, the valuation of the Company’s patent portfolios, stock-based compensation, the recoverability of deferred
tax assets and carrying value of the Company’s equity method investments. Actual results could be materially different from those
estimates, upon which the carrying values were based.
Certain
amounts recorded to reflect the Company’s share of income or losses of its equity method investee, accounted for under the equity
method, are based on estimates and the unaudited results of operations of the equity method investee and may require adjustment in the
future when the audit is complete. The Company reports its share of the results of its equity method investee on a one quarter lag basis.
NETWORK-1
TECHNOLOGIES, INC.
Note
B – Summary
of Significant Accounting Policies (continued)
| [3] | Cash
and Cash Equivalents |
The
Company maintains cash deposits in high quality financial institutions insured by the Federal Deposit Insurance Corporation ("FDIC").
Accounts at each institution are insured by the FDIC up to $250,000. At December 31, 2022 and 2021, the Company had $1,715,000 and $8,109,000,
respectively, in excess of the FDIC insured limit.
The
Company considers all highly liquid short-term investments, including certificates of deposit and money market funds, that are purchased
with an original maturity of three months or less to be cash equivalents.
The
Company’s marketable securities are comprised of certificates of deposit with original maturity greater than three months from
date of purchase, government securities, fixed income mutual funds, and a corporate bond (see Note G). At December 31, 2022 and December
31, 2021, included in marketable securities, the Company had aggregate certificates of deposit of $2,976,000 and $0, respectively. The
Company’s marketable securities are measured at fair value and are accounted for in accordance with ASU 2016-01. Unrealized holding
gains and losses on certificates of deposit, government securities, and fixed income mutual funds are recorded in net realized and unrealized
gain (loss) from investments on the consolidated statements of operations and comprehensive income (loss). Unrealized holding gains and
losses, net of the related tax effect, on corporate bonds and notes are excluded from earnings and are reported as a separate component
of stockholders’ equity until realized. Dividend and interest income are recognized when earned. Realized gains and losses are
included in earnings and are derived using the specific identification method for determining the cost of the marketable securities.
Under
ASC 606, revenue is recognized when the Company completes the licensing of its intellectual property to its licensees, in an amount that
reflects the consideration the Company expects to be entitled to in exchange for licensing its intellectual property.
The
Company determines revenue recognition through the follow steps:
| • | identification
of the license agreement; |
| • | identification
of the performance obligations in the license agreement; |
| • | determination
of the consideration for the license; |
| • | allocation
of the transaction price to the performance obligations in the contract; and |
| • | recognition
of revenue when the Company satisfies its performance obligations. |
Revenue
disaggregated by source is as follows (the Company had no revenue for the year ended December 31, 2022):
Schedule of disaggregation of revenue | |
| | | |
| | |
| |
Years
Ended December 31, | |
| |
2022 | | |
2021 | |
Fully-Paid
Licenses | |
$ | — | | |
$ | 17,000,000 | (1) |
Royalty
Bearing Licenses | |
| — | | |
| 19,029,000 | (2) |
Total
Revenue | |
$ | — | | |
$ | 36,029,000 | |
__________________________
| (1) | Includes
$17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see
Note K[1] hereof). |
| (2) | Includes
(1) $18,691,890 of royalty revenue from Cisco Systems, Inc. from resolution of a dispute
under its license agreement with the Company and (2) $337,000 of royalty revenue received
from Plantronics, Inc. |
NETWORK-1
TECHNOLOGIES, INC.
Note
B – Summary
of Significant Accounting Policies (continued)
Revenue
from the Company’s patent licensing business is typically generated from negotiated license agreements. The timing and amount of
revenue recognized from each licensee depends upon a variety of factors, including the terms of each agreement and the nature of the
obligations of the parties. These agreements may include, but not be limited to, elements related to past infringement liabilities, non-refundable
upfront license fees, and ongoing royalties on licensed products sold by the licensee. Generally, in the event of settlement of litigation
related to the Company’s assertion of patent infringement involving its intellectual property, defendants will either pay (i) a
non-refundable lump sum payment for a non-exclusive fully-paid license, or (ii) a non-refundable lump sum payment (license initiation
fee) together with an ongoing obligation to pay quarterly or monthly royalties to the Company for the life of the licensed patent.
| [6] | Equity
Method Investments |
Equity
method investments are equity securities in entities the Company does not control but over which it has the ability to exercise significant
influence. These investments are accounted for under the equity method of accounting in accordance with ASC 323, Investments —
Equity Method and Joint Ventures (see Note H hereof). Equity method investments are measured at cost minus impairment, if any, plus
or minus the Company’s share of an investee’s income or loss. The Company’s proportionate share of the income or loss
from equity method investments is recognized on a one-quarter lag. When the Company’s carrying value in an equity method investment
is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations
of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will
not record its share of such income until it equals the amount of its share of losses not previously recognized.
Upon
a sale of an equity method investment by the Company, the difference between sales proceeds and the carrying amount of the equity investment
is recognized in profit or loss. Upon the issuance of securities in an observable price transaction, the Company will account for the
share issuance by the equity method investee as if the Company had sold a proportionate share of its investment in the observable price
transaction. The Company will record a gain or loss associated with the dilution of its investment to reflect third party investments
in the investee and will increase or decrease its basis in the equity method investee accordingly. The gain or loss is recorded within
other income or expense in the Company’s consolidated statements of operations and comprehensive income (loss).
During
the year ended December 31, 2022, the Company recorded a change in its share of net losses of the equity method investee as a result
of the Company receiving new information from the equity method investee during the fourth quarter of 2022. The effect of this change
was an increase in the Company’s share of the net losses of the equity method investee of $398,000 and a corresponding decrease
in the Company’s net income, and a decrease in basic and diluted earnings of $0.02 per share.
The
Company performed an assessment to determine significance of the equity method investee under the investment, asset and income tests
utilizing the 20% threshold. The Company determined that the equity method investee satisfied the income test and has included summarized
financial data of the equity method investee in Note H hereof.
The
Company owns patents that relate to various technologies. The Company capitalizes the costs associated with acquisition, registration
and maintenance of its acquired patents and amortizes these assets over their remaining useful lives on a straight-line basis. Any further
payments made to maintain or develop the patents would be capitalized and amortized over the balance of the useful life for the patents.
| [8] | Costs
of Revenue and Related Costs |
The
Company includes in costs of revenue for the year ended December 31, 2022 and 2021 contingent legal fees payable to patent litigation
counsel, any other contractual payments to third parties related to net proceeds from monetization of patents (see Note I[1] hereof)
and incentive bonus compensation payable to its Chairman and Chief Executive Officer (see Note J[1] hereof).
NETWORK-1
TECHNOLOGIES, INC.
Note
B – Summary
of Significant Accounting Policies (continued)
The
Company accounts for income taxes in accordance with Financial Accounting Standards Board (FASB) ASC Topic 740, Income Taxes (ASC 740),
which requires the Company to use the assets and liability method of accounting for income taxes. Under the assets and liability method,
deferred income taxes are recognized for the tax consequences of temporary (timing) differences by applying enacted statutory tax rates
applicable to future years to differences between financial statement carrying amounts and the tax bases of existing assets and liabilities
and operating loss and tax credit carry forwards. Under this accounting standard, the effect on deferred income taxes of a change in
tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely
than not that some portion, or all, of a deferred tax asset will not be realized.
ASC
740-10, Accounting for Uncertainty in Income Taxes, defines uncertainty in income taxes and the evaluation of a tax position as
a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination,
including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure
a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements.
A tax position is measured at the largest amount of benefit that is greater than 50 percent likelihood of being realized upon ultimate
settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first
subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria
should be de-recognized in the first subsequent financial reporting period in which the threshold is no longer met. The Company had no
uncertain tax positions as of December 31, 2022 and 2021.
U.S.
federal, state and local income tax returns prior to 2019 are not subject to examination by any applicable tax authorities, except that
tax authorities could challenge returns (only under certain circumstances) for earlier years to the extent they generated loss carry-forwards
that are available for those future years.
| [10] | Stock-Based
Compensation |
The
Company accounts for its stock-based compensation awards to employees and directors in accordance with FASB ASC Topic 718, Compensation
— Stock
Compensation (“ASC 718”). ASC 718 requires all stock-based compensation to employees, including grants of employee
stock options and restricted stock units, to be recognized in the consolidated statements of operations and comprehensive income (loss)
based on their grant date fair values.
Compensation
expense related to awards to employees is recognized on a straight-line basis based on the grant date fair value over the associated
service period of the award, which is generally the vesting term. The Company uses the Black-Scholes option pricing model to determine
the grant date fair value of options granted. The fair value of restricted stock units is determined based on the number of shares underlying
the grant and either the quoted market price of the Company’s common stock on the date of grant for time-based and performance-based
awards, or the fair value on the date of grant using the Monte Carlo Simulation model for market-based awards.
The
Company reports earnings per share in accordance with U.S. GAAP, which requires presentation of basic and diluted earnings per share
in conjunction with the disclosure of the methodology used in computing such earnings per share. Basic earnings per share excludes dilution
and is computed by dividing income available to common shareholders by the weighted average common shares outstanding during the period.
Diluted earnings per share takes into account the potential dilution that could occur if securities or other contracts, such as warrants
and options to purchase common stock were exercised and shares were issued pursuant to outstanding restricted stock units. Common stock
equivalents having an anti-dilutive effect on earnings per share are excluded from the calculation of diluted earnings per share.
NETWORK-1
TECHNOLOGIES, INC.
Note
B – Summary
of Significant Accounting Policies (continued)
| [12] | Fair
Value Measurements |
ASC
Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid
to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction
between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification
based on observable and unobservable inputs when measuring fair value.
There
are three levels of inputs that may be used to measure fair value:
Level
1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.
Level
2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets
or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
Level
3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates
and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies,
or similar techniques.
The
carrying value of the Company’s financial instruments, including cash and cash equivalents and accounts payable, approximates fair
value because of the short-term nature of these financial instruments.
The
Company’s marketable securities are classified within Level 1 because they are valued using quoted market prices in an active market.
The
Company’s equity method investment is measured on a non-recurring basis and is classified within Level 2 as it is valued using
an observable price transaction for similar assets in a market that is not active (see Note B[6] and Note H hereof).
| [13] | Carrying
Value, Recoverability and Impairment of Long-Lived Assets |
An
impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable and exceeds its
fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash
flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the carrying
amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount by
which the carrying amount of a long-lived asset (asset group) exceeds its fair value. If an impairment loss is recognized, the adjusted
carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset, the new cost basis shall be depreciated
(amortized) over the remaining useful life of that asset. Restoration of a previously recognized impairment loss is prohibited. At December
31, 2022 and 2021, there was no impairment to the Company’s patents and equity investment.
The
Company’s equity investment in ILiAD is evaluated on a non-recurring basis for impairment, when and if a triggering event occurs.
NETWORK-1
TECHNOLOGIES, INC.
Note
B – Summary
of Significant Accounting Policies (continued)
Under
ASC 842, the Company determines if an arrangement is a lease at inception. Right-of-Use (“ROU”) assets and related lease
obligations are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this
purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As the Company's lease does
not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date
in determining the present value of lease payments. The Company's determined incremental borrowing rate is a hypothetical rate based
on its understanding of what the Company's credit rating would be. The ROU asset also includes any lease payments made prior to commencement
and is recorded net of any lease incentives received and net of the deferred rent balance on the date of implementation. The Company's
lease terms may include options to extend or terminate the lease when it is reasonably certain that it will exercise such options. As
permitted under ASC 842, the Company has elected to not recognize ROU assets and related lease obligations for leases with terms of twelve
months or less.
Cash
dividends are recorded when declared by the Company’s Board of Directors. Common stock dividends are charged against retained earnings
when declared or paid (see Note O hereof).
Stock-based
compensation in the 2021 consolidated statements of operations and comprehensive income (loss) have been recast and reclassified to conform
to the current year’s presentation.
Note
C – Patents
The
Company’s intangible assets at December 31, 2022 include patents with estimated remaining economic useful lives ranging from 0.50
to 16.50 years. For all periods presented, all the Company’s patents were subject to amortization. The gross carrying amounts and
accumulated amortization related to acquired intangible assets as of December 31, 2022 and 2021 were as follows:
Schedule of patent | |
| | | |
| | |
| |
2022 | | |
2021 | |
Gross carrying amount | |
$ | 8,473,000 | | |
$ | 7,949,000 | |
Accumulated amortization | |
| (6,881,000 | ) | |
| (6,565,000 | ) |
Patents, net | |
$ | 1,592,000 | | |
$ | 1,384,000 | |
Amortization
expense for the years ended December 31, 2022 and 2021 was $316,000 and $295,000, respectively. Future amortization of current intangible
assets, net is as follows:
Schedule of future amortization of current intangible | | |
| | |
For the years ended December 31, | | |
| |
2023 | | |
$ | 266,000 | |
2024 | | |
| 120,000 | |
2025 | | |
| 120,000 | |
2026 | | |
| 120,000 | |
2027 | | |
| 119,000 | |
Thereafter | | |
| 847,000 | |
Total | | |
$ | 1,592,000 | |
| | |
| | |
Two
patents within the Cox Patent Portfolio expire in July 2023 and November 2023, and the balance of the patents within such portfolio have
expired. The expiration dates of patents within the Company’s M2M/IoT Patent Portfolio range from September 2033 to May 2034. The
expiration dates within the Company’s HFT Patent Portfolio range from October 31, 2039 to November 1, 2039. All of the patents
within the Company’s Mirror Worlds Patent Portfolio expired and the Remote Power Patent expired.
NETWORK-1
TECHNOLOGIES, INC.
Note
D – Income (Loss) Per Share
Basic
Income (Loss) per share is calculated by dividing the net income (loss) by the weighted average number of outstanding common shares during
the period. Diluted per share data included the dilutive effects of stock options and restricted stock units. Potentially dilutive shares
of 625,000 and 12,500 at December 31, 2022 and 2021, respectively, consist of restricted stock units. However, as the Company generated
a net loss in 2022, all potentially dilutive shares were not reflected in diluted net loss per share because the impact of such instruments
was anti-dilutive. Computations of basic and diluted weighted average common shares outstanding are as follows:
Schedule of earnings per share | |
| | | |
| | |
| |
2022 | | |
2021 | |
| |
| | |
| |
Weighted-average common shares outstanding
– basic | |
| 23,825,917 | | |
| 24,136,821 | |
| |
| | | |
| | |
Dilutive effect of restricted stock
units and stock options | |
| — | | |
| 393,747 | |
| |
| | | |
| | |
Weighted-average common shares
outstanding – diluted | |
| 23,825,917 | | |
| 24,530,568 | |
| |
| | | |
| | |
Restricted stock units excluded
from the computation of diluted income per share because the effect of inclusion would have been anti-dilutive | |
| 625,000 | | |
| 12,500 | |
Note
E – Income Taxes
Significant
components of the income taxes were as follows for the years ended December 31, 2022 and 2021.
Schedule of components of the income taxes | |
| | | |
| | |
| |
2022 | | |
2021 | |
Current | |
| |
State and local | |
$ | — | | |
$ | 144,000 | |
Federal | |
| — | | |
| 2,808,000 | |
Total Current Tax Expense (Benefit) | |
$ | — | | |
$ | 2,952,000 | |
| |
| | | |
| | |
Deferred | |
| | | |
| | |
State and local | |
| 56,000 | | |
| 83,000 | |
Federal | |
| 551,000 | | |
| 1,425,000 | |
Total Deferred Tax Expense | |
| 607,000 | | |
| 1,508,000 | |
| |
| | | |
| | |
Total Income Taxes | |
$ | 607,000 | | |
$ | 4,460,000 | |
Significant
components of deferred tax assets (liability) as of December 31, 2022 and 2021 consisted of the following:
Schedule of components of deferred
tax assets and liability | |
| | | |
| | |
| |
2022 | | |
2021 | |
Deferred tax assets (liability): Net
operating loss carryforward | |
$ | 477,000 | | |
$ | — | |
Capital loss
carryforward | |
| 331,000 | | |
| — | |
Stock options
and RSU | |
| 30,000 | | |
| — | |
Valuation allowance | |
| (838,000 | ) | |
| — | |
| |
| | | |
| | |
| |
| | | |
| | |
Deferred
Tax Liability(1) | |
| (1,161,000 | ) | |
| (554,000 | ) |
Total deferred tax liability | |
$ | (1,161,000 | ) | |
$ | (554,000 | ) |
_________________________
(1)
Deferred tax liability primarily as a result of a temporary difference related to the Company’s equity method investment.
NETWORK-1
TECHNOLOGIES, INC.
Note
E – Income Taxes (continued)
As
of December 31, 2022, the Company’s estimated aggregate total net operating loss carryforwards (NOLs) were $2,168,000
for U.S. federal tax purposes with an indefinite
life. At December 31, 2022, the Company had deferred tax assets of $838,000,
which were offset by a valuation allowance of $838,000
as it was determined that it is more likely than
not that the deferred tax assets would not be realized. At December 31, 2022, the Company had a deferred tax liability position of $1,161,000.
The
reconciliation between the taxes as shown and the amount that would be computed by applying the statutory federal income tax rate to
the net income before income taxes is as follows:
Schedule of reconciliation of income tax | |
| | |
| |
| |
Years Ended | |
| |
December
31, | |
| |
2022 | | |
2021 | |
| |
| | |
| |
Income tax - statutory rate | |
| 21.00% | | |
| 21.00% | |
Permanent differences | |
| (8.40)% | | |
| 1.69% | |
Change in valuation allowance | |
| (48.79)% | | |
| —% | |
State | |
| 1.28% | | |
| 1.11% | |
Other | |
| (0.43)% | | |
| —% | |
Total | |
| (35.34)% | | |
| 23.80% | |
On
August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for,
among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and
certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed
on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally
1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise
tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value
of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of Treasury
has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.
The excise tax applies in cases where the total value of the stock repurchased during the taxable year exceeds $1,000,000.
The
personal holding company (“PHC”) rules under the Internal Revenue Code impose a 20% tax on a PHC’s undistributed personal
holding company income (“UPHCI”), which means, in general, taxable income subject to certain adjustments. For a corporation
to be classified as a PHC, it must satisfy two tests: (i) that more than 50% in value of its outstanding shares must be owned directly
or indirectly by five or fewer individuals at any time during the second half of the year (after applying constructive ownership rules
to attribute stock owned by entities to their beneficial owners and among certain family members and other related parties) (the “Ownership
Test”) and (ii) at least 60% of its adjusted ordinary gross income for a taxable year consists of dividends, interest, royalties,
annuities and rents (the “Income Test”). During the second half of 2022, based on available information concerning the Company’s
shareholder ownership, the Company did not satisfy the Ownership Test and thus the Company was not a PHC for 2022. However, the Company
may subsequently be determined to be a PHC in 2023 or in future years if it satisfies both the Ownership Test and the Income Test. If
the Company were to become a PHC in any future year, it would be subject to an additional 20% tax on its UPHCI. In such event, the Company
may issue a special cash dividend, to its shareholders in an amount equal to the UPHCI rather than incur the additional 20% tax.
NETWORK-1
TECHNOLOGIES, INC.
Note
F – Stockholders’ Equity
The
Company adopted a new 2022 Stock Incentive Plan, (the “2022 Plan”), approved by its Board of Directors on July 25, 2022 and
its stockholders on September 20, 2022. The 2022 Plan provides for the grant of any or all of the following types of awards: (a) stock
options, (b) restricted stock, (c) deferred stock, (d) stock appreciation rights, and (e) other stock-based awards including restricted
stock units. Awards under the 2022 Plan may be granted singly, in combination, or in tandem. Subject to standard anti-dilution adjustments
as provided, the 2022 Plan provides for an aggregate of 2,300,000 shares of the Company’s common stock to be available for distribution.
The Company’s Compensation Committee generally has the authority to administer the 2022 Plan, determine participants who will be
granted awards, the size and types of awards, the terms and conditions of awards and the form and content of the award agreements representing
awards. Awards under the 2022 Plan may be granted to employees, directors and consultants of the Company and its subsidiaries. As of
December 31, 2022, there were 2,300,000 shares of common stock available for issuance under the 2022 Plan.
As
of December 31, 2022, there were 625,000 shares of common stock subject to outstanding awards under the Company 2013 Stock Incentive
Plan (“2013 Plan”). The Company discontinued issuing awards under its 2013 Plan as a result of the adoption of the 2022 Plan.
| [1] | Restricted
Stock Units |
A
summary of restricted stock units granted during the years ended December 31, 2022 and December 31, 2021 is as follows (each restricted
stock unit represents the contingent right to receive one share of the Company’s common stock):
Schedule of restricted stock units | |
| | | |
| | | |
| | | |
| | |
| |
2022 | | |
2021 | |
| |
Number
of
Shares | | |
Weighted-Average
Grant Date Fair Value | | |
Number of
Shares | | |
Weighted-Average
Grant Date Fair Value | |
Balance of restricted stock units outstanding at beginning of
year | |
| 12,500 | | |
$ | 3.36 | | |
| 162,500 | | |
$ | 2.25 | |
Grants of restricted stock units | |
| 670,000 | | |
| 1.92 | | |
| 45,000 | | |
| 3.51 | |
Vested restricted stock units | |
| (57,500 | ) | |
| (2.73 | ) | |
| (195,000 | ) | |
| (2.47 | ) |
Balance of restricted stock units outstanding at end of year | |
| 625,000 | | |
$ | 1.87 | | |
| 12,500 | | |
$ | 3.36 | |
Restricted
stock unit compensation expense was $585,000 for the year ended December 31, 2022 and $238,000 for the year ended December 31, 2021.
The
Company has an aggregate of $736,000 of unrecognized restricted stock unit compensation expense as of December 31, 2022 to be expensed
over a weighted average period of 2.61 years.
The
fair value of restricted stock units is determined based on the number of shares granted and the quoted market price of the Company’s
common stock on the date of grant for time-based and performance-based awards and fair value at grant date using the Monte Carlo simulation
model for market-based awards. The key inputs into the Monte Carlo simulation used to value the restricted stock units was a risk-free
rate of 2.39%,
expected term of 4
years, expected volatility of 40%
and a stock price of $2.47.
All
of the Company’s issued restricted stock units have dividend equivalent rights. As of December 31, 2022 and 2021, there was $37,000
and $72,000 accrued for dividend equivalent rights which were included in other accrued expenses.
NETWORK-1
TECHNOLOGIES, INC.
Note
F – Stockholders’ Equity (continued)
At
December 31, 2022, there were no stock options outstanding. At December 31, 2021, one stock option to purchase 500,000 shares of
common stock was outstanding, representing an option grant outside of the 2013 Plan (issued prior to the establishment of the 2013 Plan).
The stock option had a weighted average exercise price of $1.19 and a weighted average remaining life of 0.84 years. There were no grants
of stock options during the years ended December 31, 2022 and 2021.
The
following table summarizes stock option activity for the years ended December 31:
Schedule of stock option activity | |
| | | |
| | | |
| | | |
| | |
| |
2022 | | |
2021 | |
| |
| | |
Weighted | | |
| | |
Weighted | |
| |
| | |
Average | | |
| | |
Average | |
| |
Options | | |
Exercise | | |
Options | | |
Exercise | |
| |
Outstanding | | |
Price | | |
Outstanding | | |
Price | |
Options outstanding at
beginning of year | |
| 500,000 | | |
$ | 1.19 | | |
| 500,000 | | |
$ | 1.19 | |
Granted | |
| — | | |
| — | | |
| — | | |
| — | |
Expired | |
| — | | |
| — | | |
| — | | |
| — | |
Exercised | |
| 500,000 | | |
$ | 1.19 | | |
| — | | |
| — | |
Options outstanding
at end of year | |
| — | | |
| — | | |
| 500,000 | | |
$ | 1.19 | |
Options exercisable
at end of year | |
| — | | |
| — | | |
| 500,000 | | |
$ | 1.19 | |
| |
| | | |
| | | |
| | | |
| | |
During
the year ended December 31, 2022 and 2021, the Company did not recognize any stock-based compensation related to the vesting of prior
issued stock options to employees. The Company at December 31, 2022 and 2021 had no remaining unrecognized expenses related to unvested
stock options to employees and directors. The aggregate intrinsic value of all stock options exercisable at December 31, 2022 and 2021
was $-0- and $815,000, respectively.
On
October 27, 2022, the Company’s Chairman and Chief Executive Officer exercised a stock option to purchase 500,000 shares of the
Company’s common stock at an exercise price of $1.19 per share on a net exercise (or cashless) basis. In connection with the net
exercise of the stock option, the Company’s Chairman and Chief Executive Officer delivered 334,459 shares of common stock (including
94,539 shares for withholding taxes) to the Company and received 165,541 net shares.
Note
G – Marketable Securities
Marketable
securities as of December 31, 2022 and 2021 were composed of:
Schedule of marketable securities | |
| | | |
| | | |
| | | |
| | |
| |
December
31, 2022 | |
| |
Cost
Basis | | |
Gross
Unrealized
Gains | | |
Gross
Unrealized
Losses | | |
Fair
Value | |
Government Securities | |
$ | 20,781,000 | | |
$ | 67,000 | | |
$ | — | | |
$ | 20,848,000 | |
Fixed income mutual funds | |
| 11,904,000 | | |
| — | | |
| (915,000 | ) | |
| 10,989,000 | |
Certificates of Deposit | |
| 3,019,000 | | |
| — | | |
| (43,000 | ) | |
| 2,976,000 | |
Corporate bonds
and notes | |
| 192,000 | | |
| — | | |
| (14,000 | ) | |
| 178,000 | |
Total marketable
securities | |
$ | 35,896,000 | | |
$ | 67,000 | | |
$ | (972,000 | ) | |
$ | 34,991,000 | |
| |
| | | |
| | | |
| | | |
| | |
| |
December
31, 2021 | |
| |
Cost
Basis | | |
Gross
Unrealized
Gains | | |
Gross
Unrealized
Losses | | |
Fair
Value | |
Fixed income mutual funds | |
$ | 14,462,000 | | |
| — | | |
$ | (137,000 | ) | |
$ | 14,325,000 | |
Corporate bonds
and notes | |
| 813,000 | | |
| — | | |
| (12,000 | ) | |
| 801,000 | |
Total marketable
securities | |
$ | 15,275,000 | | |
$ | — | | |
$ | (149,000 | ) | |
$ | 15,126,000 | |
NETWORK-1
TECHNOLOGIES, INC.
Note
H – Equity Investment
During
the period December 2018 through December 2022, the Company made an aggregate investment of $7,000,000 in ILiAD, a privately held clinical
stage biotechnology company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis. ILiAD is focused
on validating its proprietary intranasal vaccine, BPZE1, for the prevention of Pertussis (whooping cough). At December 31, 2022, the
Company owned approximately 6.8% of the outstanding units of ILiAD on a non-fully diluted basis and 6.3% of the outstanding units on
a fully diluted basis (after giving effect to the exercise of all outstanding options and warrants). In connection with its investment,
the Company’s Chairman and Chief Executive Officer obtained a seat on ILiAD’s Board of Managers and receives the same compensation
for service on the Board of Managers as other non-management Board members.
On
August 24, 2022, ILiAD completed a private financing of $42,836,000
of its Class D units, of which a multi-national pharmaceutical company invested $30,000,000
(the “Financing”). As part of the Financing, the Company invested $1,000,000.
This private financing represented an observable price transaction in accordance with ASC 323 and resulted in dilution in the
Company’s ownership in the ILiAD. In accordance with ASC 323-10-40-1, the Company accounted for the dilution as if
it had sold a portion of its investment and therefore recorded an unrealized gain of $3,883,000
and a corresponding increase in the carrying value of its investment in ILiAD. The Company determined the new carrying value of its
equity investment using an observable transaction price since the Company determined the securities owned by the Company were not
materially different than the securities sold by ILiAD in the Financing. The unrealized gain is reflected in the Company’s
consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2022.
In
addition, as part of the Financing, the Company converted its convertible note in the principal amount of $1,000,000 plus accrued interest
of $86,000, in accordance with its terms, into equity of ILiAD and has accounted for this investment under the equity method of accounting.
The Company recognized a gain on conversion of $271,000 which was recognized in its consolidated statements of operations and comprehensive
income (loss) for the year ended December 31, 2022.
For
the years ended December 31, 2022 and 2021, the Company recorded an allocated net loss from its equity method investment in ILiAD of
$1,639,000 and $999,000, respectively.
The
difference between the Company’s share of equity in ILiAD’s net assets and the purchase price of the investment is due
to an excess amount paid over the book value of the investment of $4,130,000,
which is accounted for as equity method goodwill.
The
Company performed an assessment to determine significance of its equity investee using the investment, asset and income tests. The Company
concluded the income test threshold was met for the year ended December 31, 2022. The following table provides certain summarized financial
information for the Company’s equity method investee for the periods presented and has been compiled from the equity investee’s
financial statement, reported on one quarter lag.
Schedule of equity method investments | |
| | | |
| | |
| |
Twelve Months
Ended September 30, | |
| |
2022 | | |
2021 | |
Loss from continuing operations | |
$ | 15,246,000 | | |
$ | 11,133,000 | |
Comprehensive loss | |
$ | 17,913,000 | | |
$ | 10,384,000 | |
| |
| | | |
| | |
NETWORK-1
TECHNOLOGIES, INC.
Note
I – Commitments and Contingencies
Russ,
August & Kabat provides legal services to the Company with respect to its pending patent litigation filed in May 2017 against Facebook,
Inc. in the U.S. District Court for the Southern District of New York relating to several patents within the Company’s Mirror Worlds
Patent Portfolio (see Note K[2] hereof). The terms of the Company’s agreement with Russ, August & Kabat provide for cash payments
on a monthly basis subject to a cap plus a contingency fee ranging between 15% and 24% of the net recovery (after deduction of expenses)
depending on the stage of the proceeding in which the result (settlement or judgment) is achieved. The Company is responsible for all
expenses incurred with respect to this litigation.
Russ,
August & Kabat also provides legal services to the Company with respect to its pending patent litigations filed in April 2014 and
December 2014 against Google Inc. and YouTube, LLC in the U.S. District Court for the Southern District of New York relating to certain
patents within the Cox Patent Portfolio acquired by the Company from Dr. Cox (see Note K[1] hereof). The terms of the Company’s
agreement with Russ, August & Kabat provide for legal fees on a full contingency basis ranging from 15% to 30% of the net recovery
(after deduction of expenses) depending on the stage of the proceeding in which the result (settlement or judgment) is achieved. The
Company is responsible for all expenses incurred with respect to this litigation.
On
March 25, 2022, the Company completed the acquisition of a new patent portfolio (HFT Patent Portfolio) currently consisting of nine U.S.
patents and two pending U.S. patents covering certain advanced technologies relating to high frequency trading, which inventions specifically
address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference
between success and failure may be measured in nanoseconds. The Company paid the seller $500,000 at the closing and has an obligation
to pay the seller an additional $500,000 in cash and $375,000 of the Company’s common stock (up to a maximum of 375,000 shares)
upon achieving certain milestones with respect to the HFT Patent Portfolio. The Company also has an additional obligation to pay the
seller 15% of the first $50 million of net proceeds (after deduction of expenses) generated by the patent portfolio and 17.5% of net
proceeds greater than $50 million.
In
connection with the Company’s acquisition of its Cox Patent Portfolio, the Company is obligated to pay Dr. Cox 12.5% of the net
proceeds (after deduction of expenses) generated by the Company from licensing, sale or enforcement of the patent portfolio. As of the
years ended December 31, 2022, and 2021, no expense was incurred with respect to the Cox Patent Portfolio. As of December 31, 2022 and
2021, no amounts were accrued with respect to the Cox Patent Portfolio.
As
part of the acquisition of the Mirror Worlds Patent Portfolio, the Company also entered into an agreement with Recognition
Interface, LLC (“Recognition”) pursuant to which Recognition received from the Company an interest in the net proceeds
realized from the monetization of the Mirror Worlds Patent Portfolio, as follows: Obligated to pay recognition, net proceeds (i) 10%
of the first $125 million of net proceeds; (ii) 15% of the next $125 million of net proceeds; and (iii) 20% of any portion of the
net proceeds in excess of $250 million. Since entering into the agreement with Recognition in May 2013, the Company has paid
Recognition an aggregate of $3,127,000 with respect to such net proceeds interest related to the Mirror Worlds Patent Portfolio. No
such payments were made by the Company to Recognition during the year ended December 31, 2022 and 2021.
In
connection with the Company’s acquisition of its M2M/IoT Patent Portfolio, the Company is obligated to pay M2M 14% of the first
$100 million of net proceeds (after deduction of expenses) and 5% of net proceeds greater than $100 million from Monetization Activities
(as defined in the acquisition agreement) related to the M2MIoT Patent Portfolio. In addition, M2M will be entitled to receive from the
Company $250,000 of additional consideration upon the occurrence of certain future events related to the patent portfolio.
NETWORK-1
TECHNOLOGIES, INC.
Note
I – Commitments and Contingencies (continued)
| [3] | Savings
and investment plan: |
The
Company has a Savings and Investment Plan which allows participants to make contributions by salary reduction pursuant to Section 401(k)
of the Internal Revenue Code of 1986. The Company also may make discretionary annual matching contributions and profit sharing in amounts
determined by the Board of Directors, subject to statutory limits. The 401(k) Plan expense for the years ended December 31, 2022
and 2021 was $78,000 and $102,000, respectively, all of which was accrued as of December 31, 2022 and 2021 and is recorded within accrued
expenses on the Company’s consolidated balance sheets.
The
Company has one operating lease for its principal office space in New Canaan, Connecticut that will expire on April 30, 2025.
There
are no material residual guarantees associated with the Company’s lease and there are no significant restrictions or covenants
included in the Company’s lease.
The
calculated incremental borrowing rate was approximately 4.2%, which was calculated based on remaining lease term of 3 years as of May
1, 2022. The remaining lease term as of December 31, 2022 was approximately 2.3 years.
There
was no sublease rental income for the year ended December 31, 2022, and the Company is not the lessor in any lease arrangement, and there
were no related-party lease agreements.
Right-of-use
lease assets and related lease obligations for the Company’s operating leases were recorded in the consolidated balance sheet as
follows:
Schedule of operating leases obligations | |
| | | |
| | |
| |
As of | | |
As of | |
| |
December
31, 2022 | | |
December
31, 2021 | |
Operating lease right-of-use
assets | |
$ | 161,000 | | |
$ | — | |
| |
| | | |
| | |
Operating lease obligations –
current | |
| 79,000 | | |
| — | |
Operating
lease obligations – non-current | |
| 94,000 | | |
| — | |
Total lease
obligations | |
$ | 173,000 | | |
$ | — | |
The
table below presents certain information related to the Company’s lease costs for the year ended December 31, 2022 and 2021:
Schedule of leases cost | |
| | | |
| | |
| |
For the
Year Ended December 31, | |
| |
2022 | | |
2021 | |
Operating lease cost | |
$ | 48,000 | | |
$ | — | |
Short-term lease cost | |
| 82,000 | | |
| 128,000 | |
Total lease cost | |
$ | 130,000 | | |
$ | 128,000 | |
Future
lease payments included in the measurement of lease liabilities on the consolidated balance sheet as of December 31, 2022, were as follows:
| Schedule of future minimum leases payments | | |
| | |
| | |
Operating Leases | |
| 2023 | | |
| 83,000 | |
| 2024 | | |
| 73,000 | |
| 2025 | | |
| 24,000 | |
| Total
future minimum lease payments | | |
| 180,000 | |
| Less
imputed interest | | |
| (7,000 | ) |
| Total
operating lease liability | | |
$ | 173,000 | |
NETWORK-1
TECHNOLOGIES, INC.
Note
J - Employment Arrangements and Other Agreements
[1] On
March 22, 2022, the Company entered into a new employment agreement (“Agreement”) with its Chairman and Chief Executive
Officer, pursuant to which he continues to serve as the Company’s Chairman and Chief Executive Officer for a four-year term
(“Term”), at an annual base salary of $535,000
which shall be increased by 3% per annum during the Term. The Agreement established an annual target bonus of $175,000
for the Chairman and Chief Executive Officer based upon performance. For the year ended December 31, 2022 and 2021, the
Chairman and Chief Executive Officer received an annual discretionary bonus of $175,000.
In
addition, pursuant to the Agreement, the Company granted the Chairman and Chief Executive Officer, under its 2013 Plan, 600,000 restricted
stock units (the “RSUs”, each RSU awarded by the Company to its officers, directors and consultants represents a contingent
right to receive one share of the Company’s common stock) which terms provided for vesting in four tranches, as follows: (1)
175,000 RSUs which shall vest 100,000 RSUs on March 22, 2023 and 75,000 RSUs on March 22, 2024, subject to the Chairman and Chief Executive
Officer’s continued employment by the Company through each such vesting date (the “Employment Condition”) (“Tranche
1”); (2) 150,000 RSUs shall vest if at any time during the Term that the Company’s common stock achieves a closing price
for twenty (20) consecutive trading days (“Closing Price”) of a minimum of $3.50 per share (subject to adjustment for stock
splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 2”);
(3) 150,000 RSUs shall vest if at any time during the Term that the common stock achieves a Closing Price of a minimum of $4.00 per share
(subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price
is achieved (“Tranche 3”); and (4) 125,000 RSUs shall vest if at any time during the Term, that the common stock achieves
a Closing Price of a minimum of $4.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through
the date such minimum per share Closing Price is achieved (“Tranche 4”). In the event of a Change of Control (as
defined), Termination Other Than for Cause (as defined) or a termination by the Chairman and Chief Executive Officer for Good Reason
(as defined) in each case prior to the last day of the Term, the vesting of all RSUs (Tranches 1, 2, 3 and 4) shall accelerate (and not
be subject to any conditions) and all RSUs shall become immediately fully vested. All RSUs granted by the Company to its officers, directors
or consultants have dividend equivalent rights.
Under
the terms of the Agreement, so long as the Chairman and Chief Executive Officer continues to serve as an executive officer of the Company,
whether pursuant to the Agreement or otherwise, the Chairman and Chief Executive Officer shall also receive incentive compensation in
an amount equal to 5% of the Company’s gross royalties or other payments from Licensing Activities (as defined) (without deduction
of legal fees or any other expenses) with respect to the Remote Power Patent and a 10% net interest (gross royalties and other payments
after deduction of all legal fees and litigation expenses related to licensing, enforcement and sale activities, but in no event shall
he receive less than 6.25% of the gross recovery) of the Company’s royalties and other payments relating to Licensing Activities
with respect to patents other than the Remote Power Patent (including all of the Company’s patent portfolios and its investment
in ILiAD) (collectively, the “Incentive Compensation”). During the year ended December 31, 2022 and 2021, the Chairman and
Chief Executive Officer earned Incentive Compensation of $-0- and $1,801,000, respectively.
The
Incentive Compensation shall continue to be paid to the Chairman and Chief Executive Officer for the life of each of the Company’s
patents with respect to licenses entered into with third parties during the term of his employment or at anytime thereafter, whether
he is employed by the Company or not; provided, that, the employment of the Chairman and Chief Executive Officer has not been terminated
by the Company “For Cause” (as defined) or terminated by him without “Good Reason” (as defined). In the event
of a merger or sale of substantially all of the Company’s assets, the Company has the option to extinguish the right of the Chairman
and Chief Executive Officer to receive future Incentive Compensation by payment to him of a lump sum payment, in an amount equal to the
fair market value of such future interest as determined by an independent third party expert if the parties do not reach agreement as
to such value. In the event that the Chairman and Chief Executive Officer’s employment is terminated by the Company “Other
Than For Cause” (as defined) or by him for “Good Reason” (as defined), the Chairman and Chief Executive Officer shall
also be entitled to (i) a lump sum severance payment of 12 months base salary, (ii) a pro-rated portion of the $175,000 target bonus
provided bonus criteria have been satisfied on a pro-rated basis through the calendar quarter in which the termination occurs and (iii)
accelerated vesting of all unvested options, RSUs or other awards.
NETWORK-1
TECHNOLOGIES, INC.
Note
J - Employment Arrangements and Other Agreements (continued)
In
connection with the Agreement, the Chairman and Chief Executive Officer has also agreed not to compete with the Company as follows: (i)
during the Term of the Agreement and for a period of 12 months thereafter if his employment is terminated “Other Than For Cause”
(as defined) provided he is paid his 12 months base salary severance amount and (ii) for a period of two years from the termination date,
if terminated “For Cause” by the Company or “Without Good Reason” by the Chairman and Chief Executive Officer.
[2]
The Company’s Executive Vice President serves on an at-will basis at an annual base salary of $200,000. The Executive Vice
President received a discretionary annual bonus of $25,000 and $40,000 for the year ended December 31, 2022 and 2021, respectively. On
January 18, 2022, the Company’s Executive Vice President was granted 15,000 RSUs under the 2013 Plan, 50% of such RSUs vested on
the one year anniversary of the date of grant (January 18, 2023) and 50% of such RSUs vest on the two year anniversary of the grant (January
18, 2024), subject to continued employment. On January 24, 2023, the Company’s Executive Vice President was granted 15,000 RSUs
under the 2022 Plan, 50% of such RSUs vest on the one year anniversary of the date of grant (January 24, 2024) and 50% of such RSUs vest
on the two year anniversary of the date of grant (January 24, 2025), subject to continued employment.
[3]
The Company’s former Chief Financial Officer served on an at-will basis at an annual base salary of $175,000 until his retirement
in December 2022. In connection with his retirement, the Chief Financial Officer was granted severance of 6 months base salary and certain
other benefits.
[4]
In December 2022, the Company’s Board of Directors elected a new Chief Financial Officer who serves on a consulting basis at
an annual base salary of $175,000.
Note
K – Legal Proceedings
[1]
On April 4, 2014 and December 3, 2014, the Company initiated litigation against Google Inc. (“Google”) and YouTube,
LLC (“YouTube”) in the U.S. District Court for the Southern District of New York for infringement of several of its patents
within its Cox Patent Portfolio acquired from Dr. Cox which relate to the identification of media content on the Internet. The lawsuit
alleges that Google and YouTube have infringed and continue to infringe certain of the Company’s patents by making, using, selling
and offering to sell unlicensed systems and related products and services, which include YouTube’s Content ID system. The litigations
against Google and YouTube were subject to court ordered stays which were in effect from July 2, 2015 until January 2, 2019
as a result of proceedings at the Patent Trial and Appeal Board (PTAB) and the appeals of PTAB Final Written Decisions to the U.S. Court
of Appeals for the Federal Circuit. Pursuant to a Joint Stipulation and Order Regarding Lifting of Stays, entered on January 2, 2019,
the parties agreed, among other things, that the stays with respect to the litigations were lifted. In January 2019, the two litigations
against Google and YouTube were consolidated. Discovery is complete and the parties have each submitted summary judgment motions. A trial
date has not yet been set.
[2]
On May 9, 2017, Mirror Worlds Technologies, LLC, the Company’s wholly-owned subsidiary, initiated litigation against Facebook,
Inc. (“now Meta Platforms, Inc. (“Meta”)) in the U.S. District Court for the Southern District of New York, for infringement
of U.S. Patent No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 (among the patents within the Company’s Mirror
Worlds Patent Portfolio). The lawsuit alleged that the asserted patents are infringed by Meta’s core technologies that enable Meta’s
Newsfeed and Timeline features. On May 7, 2018, Meta filed a motion for summary judgment on non-infringement. On August 11, 2018, the
Court issued an order granting Meta’s motion for summary judgment of non-infringement and dismissed the case. On August 17, 2018,
the Company filed a Notice of Appeal to appeal the summary judgment decision to the U.S. Court of Appeals for the Federal Circuit. On
January 23, 2020, the U.S. Court of Appeals for the Federal Circuit ruled in the Company’s favor and reversed the summary judgment
finding on non-infringement of the District Court and remanded the litigation to the Southern District of New York for further proceedings.
NETWORK-1
TECHNOLOGIES, INC.
Note
K – Legal Proceedings (continued)
On
March 7, 2022, the District Court entered a ruling granting in part and denying in part a motion for summary judgment by Meta. In
its ruling the Court (i) denied Meta’s motion that the asserted patents were invalid by concluding that all asserted claims
were patent eligible under §101 of the Patent Act and (ii) granted summary judgment of non-infringement in favor of
Facebook and dismissed the case. The Company strongly disagrees with the decision on non-infringement and on April 4, 2022,
the Company filed an appeal to the U.S. Court of Appeals for the Federal Circuit, which is pending.
[3]
On December 15, 2020, the Company filed a lawsuit against Netgear, Inc. (“Netgear”) in the Supreme Court of the State
of New York, County of New York, for breach of a Settlement and License Agreement, dated May 22, 2009, with the Company for failure to
make royalty payments, and provide corresponding royalty reports, to the Company based on sales of Netgear’s PoE products. On October
22, 2021, Netgear filed a Demand for Arbitration at the American Arbitration Association (AAA) seeking to arbitrate certain issues raised
in the litigation. The Company objected to jurisdiction at the AAA. On April 22, 2022, Netgear filed a counterclaim in the N.Y. court
action alleging that the Company breached the License Agreement by not offering Netgear lower royalties. On September 22, 2022, the arbitration
brought by Netgear was dismissed by the AAA on jurisdiction grounds. The case remains pending in the Supreme Court of the State of New
York, County of New York.
[4]
In October and November 2022, the Company initiated separate litigation against ten defendants for infringement of its Remote Power
Patent seeking monetary damages based upon reasonable royalties, as follows: (i) On October 6, 2022, the Company initiated such litigation
against Arista Networks, Inc., Fortinet, Inc., Honeywell International Inc. and Ubiquiti Inc. in the United States District Court, District
of Delaware; (ii) On October 27, 2022, and November 3, 2022, the Company initiated such litigation against TP-Link USA Corporation and
Hikvision USA, Inc. in the United States District Court for the Central District of California; (iii) On November 4, 2022, the Company
initiated such litigation against Panasonic Holdings Corporation and Panasonic Corporation of North America in the United States District
Court for the Eastern District of Texas (Marshall Division); and (iv) On November 8, 2022 and November 16, 2022, the Company initiated
such litigation against Antaira Technologies, LLC and Dahua Technology USA in the United States District Court for the Central District
of California.
Note
L - Concentrations
The
Company had no revenue for the year ended December 31, 2022. Revenue from the Company’s Remote Power Patent constituted 100% of
the Company’s revenue for the year ended December 31, 2021, of which two licensees constituted an aggregate of 99% of the Company’s
revenue for such year.
Note
M – Related Party Transaction
On
June 1, 2022, the Company repurchased from a director of the Company 41,500 shares of its common stock at a purchase price of $2.42 per
share or aggregate consideration of $100,430.
Note
N – Stock Repurchase Program
On
June 11, 2021, the Company’s Board of Directors authorized an extension and increase of the Share Repurchase Program to repurchase
up to $5,000,000 of the Company’s common stock over the subsequent 24-month period. The common stock may be repurchased from time
to time in open market transactions or privately negotiated transactions in the Company’s discretion. The timing and amount of
the shares repurchased are determined by management based on its evaluation of market conditions and other factors. The repurchase program
may be increased, suspended or discontinued at any time.
During
the year ended December 31, 2022, the Company repurchased an aggregate of 228,530 shares of its common stock pursuant to the Share Repurchase
Program at a cost of approximately $531,000 (exclusive of commissions) or an average price per share of $2.33.
Since
inception of the Share Repurchase Program (August 2011) through December 31, 2022, the Company has repurchased an aggregate of 9,212,664
shares of its common stock at a cost of approximately $17,758,000 (exclusive of commissions) or an average per share price of $1.93.
NETWORK-1
TECHNOLOGIES, INC.
Note
O – Dividend Policy
The
Company’s dividend policy consists of a semi-annual cash dividend of $0.05 per common share ($0.10 per common share annually) which
have been paid in March and September of each year. On February 23, 2022, the Board of Directors declared a semi-annual cash dividend
of $0.05 per share with a payment date of March 24, 2022 to all common shareholders of record as of March 9, 2022. On September 9, 2022,
the Board of Directors declared a semi-annual dividend of $0.05 per share with a payment date of September 30, 2022 to all common shareholders
of record as of September 20, 2022. The Company’s dividend policy undergoes a periodic review by the Board of Directors and is
subject to change at any time depending upon the Company’s earnings, financial requirements and other factors.
Note
P – Subsequent Events
[1]
On March 3, 2023, the Company’s Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date
of March 31, 2023 to all common shareholders of record as of March 15, 2023.
[2]
On March 3, 2023, the Company’s Board of Directors approved the grant of 15,000 RSUs to each of the Company’s three non-management
directors. The RSUs vest over a one year period in equal quarterly installments of 3,750 shares of common stock on each of March 15,
2023, June 15, 2023, September 15, 2023 and December 15, 2023.
[3]
During the period January 24, 2023 through March 10, 2023, the Company entered into settlement agreements with Arista Networks, Inc.,
Antiara Technologies LLC, Panasonic Holdings Corporation and TP-Link USA Corporation with respect to patent infringement litigation
involving its Remote Power Patent, resulting in aggregate settlement payments to the Company of $537,300 and a conditional payment of
$150,000 (see Note K[4] hereof).
PART
IV
| ITEM
15. | EXHIBITS
AND FINANCIAL STATEMENT SCHEDULES |
(a)(1) Financial
Statements:
The
following are included under Item 8 “Financial Statements and Supplementary Data”:
Report
of Independent Registered Public Accounting Firm
Consolidated
balance sheets as of December 31, 2022 and 2021
Consolidated
statements of operations and comprehensive (loss) income for the years ended December 31, 2022 and 2021
Consolidated
statements of changes in stockholders' equity for the years ended December 31, 2022 and 2021
Consolidated
statements of cash flows for the years ended December 31, 2022 and 2021
Notes
to consolidated financial statements
(a)(2) Financial
Statements Schedules:
Financial
statement schedules are omitted because the information is not applicable.
(a)(3) Exhibits:
101* Interactive
data files: *
101.INS XBRL
Instance Document.
101.SCH XBRL
Scheme Document.
101.CAL XBRL
Calculation Linkbase Document.
101.DEF XBRL
Definition Linkbase Document.
101.LAB XBRL
Label Linkbase Document.
101.PRE XBRL
Presentation Linkbase Document.
_________________________________________________________________
* Filed
herewith
+ Management
contract or compensatory plan or arrangement
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.
NETWORK-1
TECHNOLOGIES, INC.
By
/s/ Corey M. Horowitz
Corey
M. Horowitz
Chairman
and Chief Executive Officer
March
30, 2023
Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated:
NAME |
|
TITLE |
|
DATE |
|
|
|
|
|
Corey
M. Horowitz |
|
Chairman
and Chief Executive Officer, Chairman of the Board of Directors (principal executive officer) |
|
March
30, 2023 |
/s/
Robert Mahan
Robert
Mahan |
|
Chief
Financial Officer (principal financial officer and principal accounting officer) |
|
March
30, 2023 |
/s/
Jonathan Greene
Jonathan
Greene |
|
Executive
Vice President, Secretary and a Director |
|
March
30, 2023 |
/s/
Emanuel Pearlman
Emanuel
Pearlman |
|
Director |
|
March
30, 2023 |
/s/
Niv Harizman
Niv
Harizman |
|
Director |
|
March
30, 2023 |
Allison
Hoffman |
|
Director |
|
March
30, 2023 |
-49-
Network 1 Technologies (AMEX:NTIP)
過去 株価チャート
から 5 2024 まで 6 2024
Network 1 Technologies (AMEX:NTIP)
過去 株価チャート
から 6 2023 まで 6 2024